Quarterly Report • Nov 13, 2014
Quarterly Report
Open in ViewerOpens in native device viewer
KBC Group Extended Quarterly Report
'I, Luc Popelier, Chief Financial Officer of the KBC Group, certify on behalf of the Executive Committee of KBC Group NV that, to the best of my knowledge, the abbreviated financial statements included in the quarterly report are based on the relevant accounting standards and fairly present in all material respects the financial condition and results of KBC Group NV including its consolidated subsidiaries, and that the quarterly report provides a fair view of the main events, the main transactions with related parties in the period under review and their impact on the abbreviated financial statements, and an overview of the main risks and uncertainties for the remainder of the current year.'
The expectations, forecasts and statements regarding future developments that are contained in this report are, of course, based on assumptions and are contingent on a number of factors that will come into play in the future. Consequently, the actual situation may turn out to be (substantially) different.
Combined ratio (non-life insurance): [technical insurance charges, including the internal cost of settling claims / earned premiums] + [operating expenses / written premiums] (after reinsurance in each case).
Common equity ratio: [common equity tier-1 capital] / [total weighted risks]. The calculation is based on the Capital Requirements Regulation (CRR) and Capital Requirements Directive (CRD IV) approved and published by the EU, and includes in the numerator the core-capital securities sold to the government that are grandfathered by the regulator, as well as latent gains (revaluation reserve for available-for-sale assets). The minimum target set by the regulator for the common equity ratio does not take account of these latent gains.
Cost/income ratio (banking): [operating expenses of the banking activities of the group] / [total income of the banking activities of the group].
Cover ratio: [specific loan loss impairment] / [impaired loans]. For a definition of 'impaired', see 'Impaired loans ratio'. Where appropriate, the impairment charges and impaired loans in the formula may be limited to 'more than 90 days overdue'.
Credit cost ratio: [net changes in individual and portfolio-based impairment for credit risks] / [average outstanding loan portfolio]. Note that, inter alia, government bonds are not included in this formula.
Basic earnings per share: [result after tax, attributable to equity holders of the parent)] / [average number of ordinary shares, less treasury shares]. If a coupon is expected to be paid on the core-capital securities sold to the Belgian Federal and Flemish Regional governments and the additional tier-1 instruments included in equity, it will be deducted from the numerator (pro rata). If a penalty on the core-capital securities has to be paid, it will likewise be deducted.
Diluted earnings per share: [result after tax, attributable to equity holders of the parent, adjusted for interest expense (after tax) for nonmandatorily convertible bonds] / [average number of ordinary shares, less treasury shares, plus non-mandatorily convertible bonds]. If a coupon is expected to be paid on the core-capital securities sold to the Belgian Federal and Flemish Regional governments and the additional tier-1 instruments included in equity, it will be deducted from the numerator (pro rata). If a penalty on the core-capital securities has to be paid, it will likewise be deducted.
Liquidity Coverage Ratio (LCR): [stock of high quality liquid assets] / [total net cash outflow over the next 30 calendar days].
Net interest margin of the group: [net interest income of the banking activities] / [average interest-bearing assets of the banking activities]. To more closely reflect the scope of business, the definition has been reworked since 2014 (and applied retroactively) to exclude all divestments and all volatile short-term assets used for liquidity management.
Net stable funding ratio (NSFR): [available amount of stable funding] / [required amount of stable funding].
Impaired loans ratio: [impaired loans] / [total outstanding loan portfolio]. Impaired loans are loans for which full (re)payment of contractual principal and interest is deemed unlikely. This corresponds with KBC's Probability-of-Default classes 10+11+12. These loans are equivalent to 'non-performing loans' under the (new) definition used by the European Banking Authority.
Parent shareholders' equity per share: [parent shareholders' equity] / [number of ordinary shares, less treasury shares (at period-end)].
Return on allocated capital (ROAC) for a particular business unit: [result after tax, including minority interests, of a business unit] / [average capital allocated to the business unit]. The capital allocated to a business unit is based on risk-weighted assets for banking (based on Basel III) and risk-weighted asset equivalents for insurance (based on Solvency I).
Return on equity: [result after tax, attributable to equity holders of the parent] / [average parent shareholders' equity, excluding the revaluation reserve for available-for-sale assets]. If a coupon is expected to be paid on the core-capital securities sold to the Belgian Federal and Flemish Regional governments and the additional tier-1 instruments included in equity, it will be deducted from the numerator (pro rata).
Solvency ratio, insurance: [consolidated available capital of KBC Insurance] / [minimum required solvency margin of KBC Insurance].
[email protected] – www.kbc.com/ir – m.kbc.com
KBC Group NV, Investor Relations Office, Havenlaan 2, BE 1080 Brussels, Belgium
Visit www.kbc.com
KBC Group Report for 3Q2014 and 9M2014
KBC Group I Extended Quarterly Report – 3Q2014 4 This press release contains information that is subject to transparency regulations for listed companies. Date of release: 13 November 2014
KBC ended the third quarter of 2014 with a net profit of 591 million euros, compared with 317 million euros in the previous quarter and 272 million euros in the third quarter of 2013.
After excluding the impact of the legacy business (CDOs, divestments) and the valuation of own credit risk, adjusted net profit came to 477 million euros for the third quarter of 2014, compared with 287 million euros in the second quarter of 2014 and 457 million euros in the third quarter of 2013.
'The summer months of 2014 were characterised by a low interest rate environment and a weakening of the economic recovery that had set in earlier this year against a background of low inflation. It was in this context that KBC posted a net result of 591 million euros for the third quarter, or 477 million euros on an adjustedprofit basis. The group continued to record excellent commercial results: net interest income increased, with loan volumes and client deposits growing further. We also collected higher revenues in the form of fees and commissions particularly in the asset management activities. The combined ratio for our non-life insurance activities remained strong and sales of life insurance products were also up. The cost/income ratio adjusted for specific items remained robust. Loan loss impairment charges were up somewhat on the previous quarter's level but remained low overall, with a decrease being recorded in Ireland. Our total income continued to be
impacted slightly by negative marked-to-market changes in the value of derivatives used for asset/liability management purposes.
Besides these excellent commercial results, the group managed to complete the divestment programme agreed with the European Commission in 2009. The sale of KBC Deutschland was completed in September, the activities of Antwerp Diamond Bank were put into run down and the two remaining CDOs in the portfolio were collapsed. These operations heralded the completion of the divestment programme.
In the third quarter, the Belgium Business Unit generated a net result of 384 million euros, somewhat above the average figure of 375 million euros for the four preceding quarters. Compared with the previous quarter, the third quarter of 2014 was characterised by higher net interest income and net fee and commission income, a sound combined ratio for non-life insurance and increased sales of unit-linked life insurance products. Other features of the quarter under review were the reduced but still negative impact of the valuation of ALM derivatives, lower gains on the sale of financial assets, seasonally lower dividend income and a lower level of other net income. Costs were down slightly and impairment charges were up compared to the low level of the second quarter. The banking activities accounted for 80% of the net result in the quarter under review, and the insurance activities for 20%.
In the quarter under review, the Czech Republic Business Unit posted a net result of 130 million euros, somewhat below the 139-million-euro average for the four preceding quarters. Compared with the previous quarter, the results for the third quarter featured (on a comparable basis) flat net interest income and lower net fee and commission income, a lack of realised gains on the sale of financial assets, higher net results from financial instruments, a lower level of other income, a solid non-life combined ratio and increased sales of unit-linked life insurance products. Costs declined slightly and loan loss impairment charges were up on the unsustainably low level recorded in the previous quarter. Banking activities accounted for 95% of the net result in the quarter under review, and insurance activities for 5%.
In the quarter under review, the International Markets Business Unit recorded a positive net result of 27 million euros, a significant improvement on the negative 236-million-euro average for the four preceding quarters (which had been significantly affected by additional loan loss provisioning for Ireland in the fourth quarter of 2013 and by the impact of the new retail loans act in Hungary in the second quarter of 2014). Compared to the previous quarter, the third quarter of 2014 was characterised by slightly higher net interest income and strong net fee and commission income, a stable result from financial instruments at fair value and somewhat lower realised gains on bonds and shares, a deterioration in the non-life combined ratio and lower life insurance sales. It should be noted that the previous quarter had been significantly impacted by the new Hungarian act on retail loans. Costs in the third quarter were flat, and loan loss provisions fell, mainly in Ireland. Overall, the banking activities accounted for a net result of 23 million euros (positive results in Slovakia, Hungary and Bulgaria, but negative in Ireland), while the insurance activities accounted for a net result of 4 million euros.
The liquidity position of our group remains very strong, with both the LCR and NSFR being well above 100%.
Our capital position also continues to be very robust, as illustrated by a common equity ratio of 13.7% (Basel III fully loaded under the Danish compromise). In the analysis for the first nine months of the year, the repayment of 0.5 billion euros to the Flemish Regional Government at the beginning of January has been taken into account, as have the results for this nine-month period and a pro rata provision for the proposed dividend, the coupons on the additional tier-1 instruments and on the remaining state aid, which are all to be paid over 2014. The common equity ratio, therefore, continues to be well above our target of 10.5%.
This strong capital position has also been confirmed by the results of the comprehensive assessment carried out by the ECB. KBC exceeded the ECB's asset quality review and stress test thresholds and maintained a strong buffer of 2.8 percentage points (2.8 billion euros) above the ECB-imposed threshold of 5.5%, an achievement that reflects KBC's resilience.
The group welcomed the extension of the 'KBC Group anchoring agreements' made by Cera, KBC Ancora, MRBB and the other stable shareholders. They have confirmed that they intend to continue acting in concert with respect to KBC Group NV for another term of 10 years. In doing so, they will ensure continued shareholder stability and support the further development of the KBC group.
This anchoring agreement will help KBC realise its ambition of being among the best-performing, retail-focused financial institutions in Europe and becoming the reference in bank-insurance in its core markets. This aim will be achieved by strengthening in a highly cost-efficient way its bank-insurance business model for retail, SME and mid-cap clients in its core markets, by focusing on sustainable and profitable growth within the framework of solid risk, capital and liquidity management, and by creating superior client satisfaction via a seamless, multi-channel, client-centric distribution approach. The group is truly grateful for the continued trust that its clients and stakeholders have placed in the firm and its employees.'
In order to give a good insight into the ongoing business performance, KBC also provides adjusted figures that exclude a) the impact of the legacy business, i.e. the valuation of the remaining CDOs in portfolio (including fees for the related guarantee agreement with the Belgian State) and the impact of divestments, and b) the impact of the valuation of own credit risk. For the quarter under review, these items had the following impact:
| Overview KBC Group (consolidated) |
3Q2013 | 2Q2014 | 3Q2014 | 9M2013 | 9M2014 |
|---|---|---|---|---|---|
| Net result, IFRS (in millions of EUR) | 272 | 317 | 591 | 1 309 | 1 305 |
| Basic earnings per share, IFRS (in EUR)1 | -0.75 | 0.63 | 1.28 | 1.74 | 2.35 |
| Adjusted net result (in millions of EUR) | 457 | 287 | 477 | 1 300 | 1 151 |
| Basic earnings per share, based on adjusted net result (in EUR)1 | -0.30 | 0.56 | 1.00 | 1.72 | 1.99 |
| Breakdown by business unit (in millions of EUR) | |||||
| Belgium | 391 | 383 | 384 | 1 193 | 1 117 |
| Czech Republic | 157 | 140 | 130 | 435 | 408 |
| International Markets | -12 | -176 | 27 | -122 | -175 |
| Group Centre | -79 | -59 | -64 | -207 | -199 |
| Parent shareholders' equity per share (in EUR, end of period) | 28.5 | 29.5 | 30.8 | 28.5 | 30.8 |
1 Note: If a coupon is expected to be paid on the core-capital securities sold to the Belgian Federal and Flemish Regional governments and the additional tier-1 instruments included in equity, it will be deducted from the numerator (pro rata). If a penalty has to be paid on the core-capital securities, it will likewise be deducted.
A full overview of the IFRS consolidated income statement and balance sheet is provided in the 'Consolidated financial statements' section of the quarterly report. Condensed statements of comprehensive income, changes in shareholders' equity, and cash flow, as well as several notes to the accounts, are also available in the same section.
In order to provide a good insight into the ongoing business performance, KBC also publishes an overview of adjusted results, where the impact of legacy activities (divestments, CDOs) and of the valuation of own credit risk is excluded from P/L and summarised in three lines at the bottom of the presentation (see next section).
| Consolidated income statement, IFRS KBC Group (in millions of EUR) |
1Q 2013 |
2Q 2013 |
3Q 2013 |
4Q 2013 |
1Q 2014 |
2Q 2014 |
3Q 2014 |
4Q 2014 |
9M 2013 |
9M 2014 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net interest income | 1 053 | 1 003 | 1 014 | 1 008 | 1 010 | 1 056 | 1 120 | - | 3 069 | 3 185 |
| Interest income | 2 161 | 2 079 | 2 037 | 2 067 | 1 930 | 1 971 | 2 010 | - | 6 276 | 5 911 |
| Interest expense | -1 108 | -1 076 | -1 023 | -1 060 | -920 | -915 | -890 | - | -3 207 | -2 726 |
| Non-life insurance (before reinsurance) | 149 | 115 | 145 | 127 | 149 | 102 | 139 | - | 409 | 389 |
| Earned premiums | 305 | 316 | 321 | 317 | 307 | 315 | 321 | - | 942 | 944 |
| Technical charges | -156 | -201 | -176 | -190 | -158 | -214 | -183 | - | -533 | -555 |
| Life insurance (before reinsurance) | -59 | -62 | -63 | -57 | -59 | -56 | -57 | - | -185 | -171 |
| Earned premiums | 271 | 241 | 238 | 381 | 308 | 297 | 299 | - | 750 | 904 |
| Technical charges | -331 | -303 | -302 | -438 | -367 | -353 | -355 | - | -936 | -1 075 |
| Ceded reinsurance result | -12 | 13 | 1 | -6 | -17 | 19 | 4 | - | 2 | 6 |
| Dividend income | 5 | 20 | 14 | 8 | 14 | 24 | 9 | - | 39 | 47 |
| Net result from financial instruments at fair value through profit or loss |
314 | 425 | 223 | 229 | 40 | 44 | 34 | - | 962 | 118 |
| Net realised result from available-for-sale assets | 142 | 47 | 34 | 29 | 51 | 49 | 28 | - | 223 | 128 |
| Net fee and commission income | 389 | 381 | 337 | 362 | 374 | 387 | 402 | - | 1 107 | 1 163 |
| Fee and commission income | 636 | 560 | 507 | 564 | 557 | 533 | 579 | - | 1 704 | 1 668 |
| Fee and commission expense | -247 | -179 | -170 | -202 | -182 | -147 | -177 | - | -596 | -505 |
| Other net income | 76 | -20 | 51 | 15 | 52 | -99 | 73 | - | 107 | 26 |
| Total income | 2 058 | 1 921 | 1 754 | 1 715 | 1 615 | 1 526 | 1 752 | - | 5 733 | 4 892 |
| Operating expenses | -1 033 | -924 | -918 | -968 | -973 | -933 | -923 | - | -2 875 | -2 829 |
| Impairment | -350 | -275 | -362 | -940 | -114 | -142 | -58 | - | -987 | -313 |
| on loans and receivables | -293 | -254 | -230 | -937 | -102 | -136 | -190 | - | -777 | -429 |
| on available-for-sale assets | -13 | -3 | -8 | -10 | -5 | -3 | -6 | - | -24 | -14 |
| on goodwill | -7 | 0 | 0 | 0 | 0 | 0 | 0 | - | -7 | 0 |
| on other | -37 | -18 | -125 | 7 | -6 | -3 | 139 | - | -179 | 130 |
| Share in results of associated companies and joint ventures |
8 | 8 | 9 | 6 | 7 | 7 | 6 | - | 24 | 19 |
| Result before tax | 683 | 729 | 483 | -187 | 535 | 457 | 777 | - | 1 895 | 1 769 |
| Income tax expense | -159 | -210 | -207 | -103 | -138 | -140 | -186 | - | -575 | -464 |
| Net post-tax result from discontinued operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | 0 | 0 |
| Result after tax | 524 | 520 | 276 | -290 | 397 | 317 | 591 | - | 1 319 | 1 305 |
| attributable to minority interests | 4 | 3 | 4 | 4 | 0 | 0 | 0 | - | 10 | 0 |
| attributable to equity holders of the parent | 520 | 517 | 272 | -294 | 397 | 317 | 591 | - | 1 309 | 1 305 |
| Basic earnings per share (EUR) | 1.25 | 1.24 | -0.75 | -0.71 | 0.45 | 0.63 | 1.28 | - | 1.74 | 2.35 |
| Diluted earnings per share (EUR) | 1.25 | 1.24 | -0.75 | -0.71 | 0.45 | 0.63 | 1.28 | - | 1.74 | 2.35 |
Note that the 2013 reference figures have been adjusted slightly following the application of the new IFRS 11 standard. This standard stipulates that joint ventures must be accounted for using the equity method instead of the proportionate consolidation method. For KBC, this applies to ČMSS, a joint venture of ČSOB in the Czech Republic. This change does not affect the net result, but has an impact on various items in the consolidated income statement.
In addition to the figures according to IFRS (previous section), KBC provides figures aimed at giving more insight into the ongoing business performance. Hence, in the overview below, the impact of legacy activities (remaining divestments, CDOs) and of the valuation of own credit risk is excluded from P/L and summarised in three lines at the bottom of the presentation (in segment reporting, these items are all included in the Group Centre). Moreover, a different accounting treatment for capitalmarket income was applied to the Belgium Business Unit (with all trading results shifting to 'Net result from financial instruments at fair value'). A full explanation of the differences between the IFRS and adjusted figures is provided under 'Notes on segment reporting' in the 'Consolidated financial statements' section of the quarterly report.
| Consolidated income statement, KBC Group (in millions of EUR) |
1Q 2013 |
2Q 2013 |
3Q 2013 |
4Q 2013 |
1Q 2014 |
2Q 2014 |
3Q 2014 |
4Q 2014 |
9M 2013 |
9M 2014 |
|---|---|---|---|---|---|---|---|---|---|---|
| Adjusted net result (i.e. excluding legacy business and own credit risk) |
||||||||||
| Net interest income | 1 018 | 976 | 999 | 996 | 1 002 | 1 047 | 1 109 | - | 2 993 | 3 158 |
| Non-life insurance (before reinsurance) | 149 | 115 | 145 | 127 | 149 | 102 | 139 | - | 409 | 389 |
| Earned premiums | 305 | 316 | 321 | 317 | 307 | 315 | 321 | - | 942 | 944 |
| Technical charges | -156 | -201 | -176 | -190 | -158 | -214 | -183 | - | -533 | -555 |
| Life insurance (before reinsurance) | -59 | -62 | -63 | -57 | -59 | -56 | -57 | - | -185 | -171 |
| Earned premiums | 271 | 241 | 238 | 381 | 308 | 297 | 299 | - | 750 | 904 |
| Technical charges | -331 | -303 | -302 | -438 | -367 | -353 | -355 | - | -936 | -1 075 |
| Ceded reinsurance result | -12 | 13 | 1 | -6 | -17 | 19 | 4 | - | 2 | 6 |
| Dividend income | 4 | 19 | 11 | 7 | 11 | 22 | 6 | - | 34 | 39 |
| Net result from financial instruments at fair value through profit or loss |
218 | 256 | 146 | 159 | 17 | 37 | 49 | - | 620 | 103 |
| Net realised result from available-for-sale assets | 96 | 46 | 42 | 29 | 50 | 49 | 27 | - | 183 | 127 |
| Net fee and commission income | 382 | 385 | 341 | 365 | 378 | 389 | 404 | - | 1 108 | 1 171 |
| Other net income | 76 | 68 | 151 | 47 | 52 | -124 | 64 | - | 296 | -8 |
| Total income | 1 872 | 1 815 | 1 773 | 1 668 | 1 584 | 1 485 | 1 746 | - | 5 459 | 4 814 |
| Operating expenses | -1 023 | -914 | -906 | -955 | -965 | -926 | -898 | - | -2 843 | -2 789 |
| Impairment | -333 | -234 | -208 | -949 | -107 | -134 | -183 | - | -775 | -424 |
| on loans and receivables | -293 | -215 | -185 | -939 | -103 | -130 | -165 | - | -693 | -398 |
| on available-for-sale assets | -13 | -3 | -2 | -3 | -5 | -3 | -6 | - | -18 | -14 |
| on goodwill | -7 | 0 | 0 | 0 | 0 | 0 | 0 | - | -7 | 0 |
| on other | -20 | -15 | -22 | -7 | 0 | 0 | -12 | - | -57 | -12 |
| Share in results of associated companies and joint ventures |
8 | 8 | 9 | 6 | 7 | 7 | 6 | - | 24 | 19 |
| Result before tax | 524 | 675 | 667 | -230 | 518 | 431 | 671 | - | 1 866 | 1 620 |
| Income tax expense | -161 | -187 | -206 | -106 | -131 | -144 | -194 | - | -555 | -469 |
| Result after tax | 363 | 487 | 460 | -336 | 387 | 288 | 477 | - | 1 310 | 1 152 |
| attributable to minority interests | 4 | 3 | 4 | 4 | 0 | 0 | 0 | - | 10 | 0 |
| attributable to equity holders of the parent | 359 | 485 | 457 | -340 | 387 | 287 | 477 | - | 1 300 | 1 151 |
| Belgium | 385 | 418 | 391 | 376 | 351 | 383 | 384 | - | 1 193 | 1 117 |
| Czech Republic | 132 | 146 | 157 | 119 | 138 | 140 | 130 | - | 435 | 408 |
| International Markets | -87 | -23 | -12 | -731 | -26 | -176 | 27 | - | -122 | -175 |
| Group Centre | -71 | -56 | -79 | -104 | -75 | -59 | -64 | - | -207 | -199 |
| Basic earnings per share (EUR) Diluted earnings per share (EUR) |
0.86 0.86 |
1.16 1.16 |
-0.30 -0.30 |
-0.82 -0.82 |
0.42 0.42 |
0.56 0.56 |
1.00 1.00 |
- - |
1.72 1.72 |
1.99 1.99 |
| Legacy business and own credit risk impact (after tax) | ||||||||||
| Legacy – gains/losses on CDOs | 165 | 180 | 34 | 65 | 16 | 30 | -24 | - | 380 | 23 |
| Legacy – divestments | 22 | -128 | -231 | -10 | -9 | 8 | 132 | - | -337 | 131 |
| MTM of own credit risk | -26 | -20 | 12 | -9 | 2 | -8 | 6 | - | -34 | 0 |
| Net result (IFRS) | ||||||||||
| Result after tax, attributable to equity holders of the parent (IFRS) |
520 | 517 | 272 | -294 | 397 | 317 | 591 | - | 1 309 | 1 305 |
Note that the 2013 reference figures have been adjusted slightly following the application of the new IFRS 11 standard. This standard stipulates that joint ventures must be accounted for using the equity method instead of the proportionate consolidation method. For KBC, this applies to ČMSS, a joint venture of ČSOB in the Czech Republic. This change does not affect the net result, but has an impact on various items in the consolidated income statement.
Adjusted net result (in millions of EUR) Adjusted net result by business unit, 3Q2014 (in millions of EUR)
The net result for the quarter under review amounted to 591 million euros. Excluding the legacy business and the impact of own credit risk, the adjusted net result came to 477 million euros, compared with 287 million euros in 2Q2014 and 457 million euros in 3Q2013.
In the non-life segment, earned premiums were up 2% quarter-on-quarter and flat year-on-year. Claims during the third quarter were substantially lower (-14%) than their quarter-earlier level (due to the hailstorms in Belgium in 2Q2014) and were up somewhat (4%) on their level in the third quarter of 2013. Nevertheless, the combined ratio came to a solid 93% year-to-date.
In the life segment, sales of life insurance products (including unit-linked products not included in premium income figures) were up 12% on their level in 2Q2014, with a significant increase in unit-linked products. Year-on-year, they were up by 50% on account of the increase in sales of guaranteed-interest products and unit-linked products.
It should be noted that the third quarter was a decent one for investment income derived from insurance activities, although down on the level of the previous quarter, with the quarter-on-quarter results being driven by higher net interest income quarter-on-quarter, but lower dividend income after a seasonally strong second quarter, and lower realised gains on available-for-sales assets in the investment portfolio. Lastly, the technical-financial result also benefited from general administrative expenses being kept strictly under control.
The net result from financial instruments at fair value amounted to 49 million euros in the quarter under review, significantly below the 90-million-euro average for the four preceding quarters. This figure was driven by dealing-room income, which
stood at a modest level in 3Q2014, whilst the quarter under review was impacted by lower negative marked-to-market valuations in respect of derivative instruments used for asset/liability management purposes. These valuations came to -46 million euros in the third quarter (compared to a quarterly average of +70 million euros in 2013 and to -57 million euros in the second quarter).
The net result for 9M2014 amounted to 1 305 million euros. Excluding the legacy business and the impact of own credit risk, the adjusted net result amounted to 1 151 million euros, compared with 1 300 million euros in 9M2013.
Premiums in the non-life segment were flat year-on-year. The claims arising from the hailstorms in Belgium resulted in a somewhat higher level of technical charges compared with 9M2013, which in turn had been affected by claims relating to flooding in the Czech Republic. Nevertheless, the combined ratio still came to a solid 93% year-to-date.
In the life segment, sales of life insurance products (including unit-linked products not included in premium income figures) were up 3% on their level in 9M2013. The increase in sales of guaranteed interest products exceeded the contraction in sales of unit-linked products.
It should be noted that the insurance results also benefited from slightly higher investment income, driven by the higher net realised result from the sale of available-for-sale assets, lower impairment charges and higher dividend income, all of which outweighed the lower level of net interest income and the net result from financial instruments at fair value. General administrative expenses were kept strictly under control and fell by 5% year-on-year.
Operating expenses came to 2 789 million euros in 9M2014, down 2% on their year-earlier level. On a comparable basis, costs decreased by 1%, with the higher bank tax in Belgium and Hungary and higher staff expenses and general administrative expenses in Ireland being offset by lower operating expenses at the Group Centre and a positive foreign exchange impact. The year-to-date cost/income ratio came to a relatively high 59%, but resulted primarily from the fact that the denominator (total income) suffered from negative marked-to-market valuations of ALM derivatives and the impact of the new act on retail loans in Hungary. Adjusted for specific items, the cost/income ratio stood at 54%.
Income tax amounted to 469 million euros for the first nine months of 2014.
The group's liquidity remains excellent, as reflected in an LCR ratio of 120% and an NSFR ratio of 109% at the end of the third quarter.
| Highlights of consolidated balance sheet * KBC Group (in millions of EUR) |
31-03- 2013 |
30-06- 2013 |
30-09- 2013 |
31-12- 2013 |
31-03- 2014 |
30-06- 2014 |
30-09- 2014 |
31-12- 2014 |
|---|---|---|---|---|---|---|---|---|
| Total assets | 255 753 | 250 557 | 247 530 | 238 686 | 246 179 | 252 768 | 251 612 | - |
| Loans and advances to customers | 127 112 | 129 179 | 125 795 | 120 371 | 120 810 | 124 661 | 125 898 | - |
| Securities (equity and debt instruments) | 64 777 | 65 435 | 63 854 | 64 904 | 66 313 | 68 380 | 69 530 | - |
| Deposits from customers and debt certificates | 164 766 | 164 213 | 166 223 | 161 135 | 163 838 | 166 407 | 166 843 | - |
| Technical provisions, before reinsurance | 18 836 | 18 805 | 18 803 | 18 701 | 18 941 | 19 007 | 19 065 | - |
| Liabilities under investment contracts, insurance | 11 664 | 11 606 | 11 684 | 11 787 | 11 976 | 12 322 | 12 540 | - |
| Parent shareholders' equity | 12 505 | 12 119 | 11 895 | 11 826 | 11 968 | 12 318 | 12 840 | - |
| Non-voting core-capital securities | 3 500 | 3 500 | 2 333 | 2 333 | 2 000 | 2 000 | 2 000 | - |
* Note that the 2013 reference figures have been adjusted slightly following the application of the new IFRS 11 standard. This standard stipulates that joint ventures must be accounted for using the equity method instead of the proportionate consolidation method. For KBC, this applies to ČMSS, a joint venture of ČSOB in the Czech Republic. This change does not affect equity, but has an impact on various items in the consolidated balance sheet. Moreover, in accordance with IFRS 5, the assets and liabilities of a number of divestments have been reallocated to 'Non-current assets held for sale and disposal groups' and 'Liabilities associated with disposal groups', which slightly distorts the comparison between periods.
| Selected ratios FY2013 KBC Group (consolidated) |
9M2014 | |
|---|---|---|
| Profitability and efficiency (based on adjusted net result) | ||
| Return on equity* | 9% | 12% |
| Cost/income ratio, banking | 52% | 59% |
| Combined ratio, non-life insurance | 94% | 93% |
| Solvency | ||
| Common equity ratio (Basel III, fully loaded, including remaining state aid) | 12.8% | 13.7% |
| Credit risk | ||
| Credit cost ratio | 1.21% | 0.41% |
| Impaired loans ratio | 10.2% | 10.3% |
| for loans more than 90 days overdue | 5.9% | 6.0% |
| * If a coupon is expected to be paid on the core-capital securities sold to the Belgian Federal and Flemish Regional governments and the additional tier-1 instruments included in equity, it |
will be deducted from the numerator (pro rata).
Note: a number of ratios have been affected (with retroactive application) by changes due to the implementation of IFRS11, Basel III and the abolished carve-out of the zero weighting of domestic government bonds.
The 'K&H for the underprivileged' programme provides support to the 47 most disadvantaged micro-regions in the areas of children's healthcare, performing arts, pre-adult education and sports.
In Belgium, KBC continues to focus on mobility. Teleworking has become firmly embedded in KBC's corporate culture and commuter travel at KBC Belgium is expected to drop by 15 million kilometres in 2014.
KBC Group Analysis of 3Q2014 results by business unit
In the segment reporting presentation, the segments, or business units, are essentially:
A more detailed definition is provided in the sections per business unit below.
In addition to the figures according to IFRS, KBC provides figures aimed at giving more insight into the ongoing business performance. This means that, over and above the IFRS income statement, an adjusted income statement is provided in which a limited number of non-operating items is excluded from P/L and summarised in three lines at the bottom of the reporting presentation. Segment reporting is based on this reworked presentation.
The items in question are:
In the segment reporting presentation, these items are all assigned to the Group Centre (hence, there is no additional 'adjusted' net result total for the other business units).
In order to reflect the increased capital target (see the Investor Day presentation of 17 June 2014), changes were also made in calculating allocated capital (by applying a factor of 10.5% on risk weighted assets instead of 10%) and the resulting ROAC. All the quarterly figures for 2014 have been restated (though the effect is limited).
The Belgium Business unit includes the activities of KBC Bank NV and KBC Insurance NV, as well as their Belgian subsidiaries (CBC Banque, KBC Asset Management, KBC Lease Group, KBC Securities, KBC Group Re, etc.). Results related to legacy businesses and the valuation of own credit risk have been moved to the Group Centre.
| Income statement, Belgium Business Unit (in millions of EUR) |
1Q2013 | 2Q2013 | 3Q2013 | 4Q2013 | 1Q2014 | 2Q2014 | 3Q2014 | 4Q2014 |
|---|---|---|---|---|---|---|---|---|
| Net interest income | 658 | 640 | 670 | 680 | 696 | 697 | 735 | - |
| Non-life insurance (before reinsurance) | 117 | 96 | 111 | 86 | 118 | 66 | 113 | - |
| Earned premiums | 234 | 239 | 241 | 241 | 236 | 240 | 244 | - |
| Technical charges | -117 | -143 | -130 | -155 | -118 | -174 | -132 | - |
| Life insurance (before reinsurance) | -69 | -69 | -70 | -66 | -65 | -65 | -66 | - |
| Earned premiums | 195 | 180 | 162 | 295 | 255 | 234 | 228 | - |
| Technical charges | -263 | -249 | -232 | -361 | -320 | -299 | -293 | - |
| Ceded reinsurance result | -10 | 4 | 0 | -1 | -17 | 22 | -2 | - |
| Dividend income | 4 | 18 | 11 | 7 | 11 | 20 | 6 | - |
| Net result from financial instruments at fair value through profit or loss |
135 | 201 | 83 | 125 | -19 | -6 | 27 | - |
| Net realised result from available-for-sale assets | 85 | 30 | 40 | 15 | 42 | 33 | 18 | - |
| Net fee and commission income | 291 | 288 | 240 | 241 | 278 | 283 | 296 | - |
| Other net income | 66 | 49 | 124 | 53 | 42 | 104 | 58 | - |
| Total income | 1 278 | 1 257 | 1 210 | 1 141 | 1 086 | 1 154 | 1 185 | - |
| Operating expenses | -575 | -544 | -568 | -562 | -555 | -567 | -562 | - |
| Impairment | -140 | -98 | -65 | -59 | -38 | -36 | -81 | - |
| on loans and receivables | -138 | -82 | -43 | -65 | -34 | -34 | -64 | - |
| on available-for-sale assets | -2 | -2 | -1 | -2 | -5 | -3 | -5 | - |
| on goodwill other |
0 1 |
0 -14 |
0 -21 |
0 7 |
0 0 |
0 1 |
0 -12 |
- - |
| Share in results of associated companies and joint ventures |
0 | 0 | 0 | 0 | -1 | 0 | 0 | - |
| Result before tax | 562 | 615 | 577 | 519 | 492 | 551 | 541 | - |
| Income tax expense | -176 | -198 | -186 | -142 | -142 | -168 | -157 | - |
| Result after tax | 386 | 417 | 391 | 377 | 351 | 383 | 384 | - |
| attributable to minority interests | 1 | -1 | 0 | 0 | 0 | 0 | 0 | - |
| attributable to equity holders of the parent | 385 | 418 | 391 | 376 | 351 | 383 | 384 | - |
| Banking | 300 | 329 | 307 | 319 | 261 | 297 | 306 | - |
| Insurance | 85 | 89 | 83 | 57 | 90 | 86 | 78 | - |
| Risk-weighted assets banking (end of period, Basel III) | 42 287 | 40 947 | 38 491 | 40 307 | 40 858 | 41 032 | 42 235 | - |
| Required capital insurance (end of period, Solvency I) | 839 | 842 | 846 | 850 | 851 | 854 | 859 | - |
| Allocated capital (end of period) | 5 697 | 5 569 | 5 330 | 5 518 | 5 779 | 5 803 | 5 939 | - |
| Return on allocated capital (ROAC) | 26% | 29% | 29% | 28% | 24% | 26% | 26% | - |
| Cost/income ratio, banking | 46% | 44% | 49% | 49% | 53% | 51% | 49% | - |
| Combined ratio, non-life insurance | 85% | 93% | 90% | 103% | 88% | 98% | 92% | - |
| Net interest margin, banking | 1.78% | 1.72% | 1.81% | 1.87% | 1.98% | 1.96% | 2.04% | - |
Note that in the IFRS accounts, income related to trading activities is split across different components. In the figures for the Belgium Business Unit, all trading income components related to KBC Bank Belgium have been recognised under 'Net result from financial instruments at fair value'. This shift does not apply to the other business units for reasons of materiality.
In 3Q2014, the Belgium Business Unit generated a net result of 384 million, somewhat above the average figure of 375 million for the four preceding quarters. Compared with the previous quarter, 3Q2014 was characterised by higher net interest income and net fee and commission income, a sound combined ratio for non-life insurance, increased sales of unitlinked life insurance products, and a smaller but still negative impact of the valuation of ALM derivatives, lower gains on the sale of financial assets, seasonally lower dividend income and a lower level of other net income. Costs were down slightly and impairment charges were up compared to the low level of the second quarter. The banking activities accounted for 80% of the net result in the quarter under review, and the insurance activities for 20%.
Net interest income stood at 735 million in the quarter under review, up by 5% on the previous quarter and by as much as 10% on the year-earlier quarter. Both quarter-on-quarter and year-on-year, net interest income benefited from higher lending-related income, lower term deposit funding costs (drop in volume and pricing), cuts in interest rates for saving accounts, a bigger banking bond portfolio, and a number of one-off items (higher level of prepayment fees resulting from loan refinancings in the third quarter, …), despite the negative impact of lower reinvestment yields (and, year-on-year, the deliberate reduction in the loan portfolio at the foreign branches).
At the end of September 2014, the Belgium Business Unit's loan book ('Loans and advances to customers, excluding reverse repos') amounted to 84 billion, up 1% quarter-on-quarter and 2% year-on-year. Deposits ('Deposits from customers and debt certificates, excluding repos') stood at 104 billion, up 3% on the previous quarter's level and up approximately 4% year-on-year.
On the whole, the net interest margin in Belgium widened by 8 basis points quarter-on-quarter and by 23 basis points year-on-year, amounting to 204 basis points in 3Q2014 (199 basis points for the first nine months of 2014).
In the non-life business, earned premium income stood at 244 million, up 2% quarter-on-quarter and 1% year-onyear. The quarter-on-quarter increase is mainly situated in the 'Fire and other damage to property' class. Technical non-life charges amounted to 132 million, down 24% quarter-on-quarter (the previous quarter had been significantly affected by a hailstorm) and up 1% year-on-year. After taking into account the effect of ceded reinsurance, earned premiums less technical charges stood at 111 million in the quarter under review, up on the 88 million in 2Q2014 and in line with the 111 million in 3Q2013. As a result, the combined ratio came to a favourable 92% in the quarter under review, which – combined with the excellent performance in the first quarter and the negative impact of the hailstorm in the second quarter – also amounted to 92% year-to-date, compared to the 93% recorded for FY2013.
In the life business, insurance sales (including unit-linked products which are not included in the premium figures under IFRS) stood at 425 million in 3Q2014 (still being impacted by the low interest rate climate), though they were up somewhat on the 376 million recorded in the previous quarter and the 254 million recorded in the yearearlier quarter. The increase in life insurance sales in the quarter under review was due entirely to unit-linked products, which now account for close to half of total life sales.
At the end of September 2014, the life reserves of the Belgium Business Unit (including the liabilities under unitlinked contracts) amounted to 26 billion (up 4% year-on-year).
Note that the life and non-life insurance results described above only relate to premiums and technical charges. The insurance bottom line is also clearly impacted by investment income, costs, taxes, etc., all of which are analysed from a group perspective (i.e. banking and insurance together) in this section.
Total net fee and commission income amounted to 296 million in the quarter under review, up 5% compared to the previous quarter, and up by as much as 23% on its year–earlier level. Quarter-on-quarter, the increase was due primarily to higher management fee income on mutual funds (increased level of assets under management (AUM), among other things) and, to a lesser extent, to a higher amount in entry fees for mutual funds (summer campaign) and class-23 life insurance sales as well as higher payment-services-related fee income. The 23% year-on-year increase in net fee and commission income was essentially due to significantly higher entry and management fees for mutual funds (increased AUM, see below) and higher fees relating to class-23 life insurance sales.
Assets under management in this business unit stood at 167 billion at the end of September 2014, up 4% on the level recorded three months previously, roughly half of which was due to net inflows and the other half to a
positive price effect. AUM were up by as much as 13% on their year-earlier level, some 4 percentage points of which was attributable to net inflows and 9 percentage points to a positive price effect.
Trading and fair value income (recorded under 'Net result from financial instruments at fair value through profit or loss') came to 27 million in the quarter under review, below the 46 million average for the four preceding quarters. The 3Q2014 figure includes a negative marked-to-market valuation of ALM derivatives arising partly as a result of decreasing long-term IRS rates (impact of -32 million in 3Q2014, -63 million in 2Q2014 and +27 million in 3Q2013). Dividend income stood at 6 million, down on the 11 million recorded in the year-earlier quarter (which had benefited from a one-off item) and down on the 20 million recorded in 2Q2014, the quarter in which dividends are traditionally received. The realised result from available-for-sale assets amounted to 18 million, lower than the average figure of 33 million for the four preceding quarters. It included 11 million in net gains from the sale of shares and 8 million from the sale of bonds. Other net income amounted to 58 million, lower than the 81 million average for the four preceding quarters, because the 3Q2014 figure did not include any significant positive one-off items, unlike the previous quarters.
The operating expenses of the Belgium Business Unit totalled 562 million in the quarter under review, down 1% on the previous quarter. This came about primarily because of slightly lower marketing, ICT and staff expenses and the fact that 2Q2014 included 5 million in provisioning for invoices related to the AQR exercise. Compared to the year-earlier quarter, costs also declined by 1%, due primarily to the fact that the year-earlier period had been impacted by costs related to staff transitional arrangements, but this was partly offset by somewhat higher bank taxes, among other things.
The cost/income ratio in the quarter under review amounted to a sound 49%, or 51% year-to-date, as opposed to an excellent 47% in FY2013. Note, however, that the numerator of this ratio included significantly negative marked-to-market valuations of ALM derivatives in 9M2014, while the ratio benefited from large positive markedto-market valuations of such derivatives in the corresponding period of 2013. Excluding that item and a number of exceptional items, the 'sustainable' cost/income ratio stood at 48% in 3Q2014 and 49% in 9M2014, compared to the 51% recorded for FY2013.
Impairment on loans and receivables (loan loss provisions) amounted to 64 million in 3Q2014, up on the relatively low 34 million and 43 million figures in the previous and year-earlier quarters, respectively. The quarter-on-quarter and year-on-year increase relates mainly to a number of (large) Belgian corporate loans and to the foreign branches of KBC Bank in 3Q2014. Despite this increase, the credit cost ratio for 9M2014 stood at what is still a favourable 20 basis points, an improvement on the 37 basis points recorded in FY2013.
At the end of 3Q2014, some 4.6% of the Belgian loan book was impaired, a slight improvement on the 4.7% recorded at the start of the year. Impaired loans that are more than 90 days overdue (referred to as 'nonperforming loans' in previous reports) accounted for 2.5%, the same level as recorded at the start of the year.
All other impairment charges combined totalled 17 million in the quarter under review and related mainly to impairments on the available-for-sale securities in portfolio and to software.
The Czech Republic Business Unit includes all of KBC's activities in the Czech Republic. This encompasses the ČSOB group (operating mainly under the brands ČSOB, Era, Postal Savings Bank, Hypotečni banka and ČMSS), the insurance company ČSOB Pojišt'ovna, ČSOB Asset Management and Patria Finance.
| Income statement, Czech Republic Business Unit (in millions of EUR) |
1Q2013 | 2Q2013 | 3Q2013 | 4Q2013 | 1Q2014 | 2Q2014 | 3Q2014 | 4Q2014 |
|---|---|---|---|---|---|---|---|---|
| Net interest income | 230 | 232 | 230 | 214 | 219 | 220 | 211 | - |
| Non-life insurance (before reinsurance) | 16 | 3 | 17 | 26 | 16 | 19 | 19 | - |
| Earned premiums | 41 | 42 | 43 | 43 | 39 | 41 | 42 | - |
| Technical charges | -25 | -39 | -27 | -17 | -23 | -21 | -23 | - |
| Life insurance (before reinsurance) | 7 | 5 | 7 | 6 | 6 | 6 | 6 | - |
| Earned premiums | 48 | 36 | 53 | 61 | 32 | 41 | 51 | - |
| Technical charges | -41 | -30 | -47 | -55 | -26 | -35 | -45 | - |
| Ceded reinsurance result | -1 | 10 | 0 | -4 | -1 | -3 | -2 | - |
| Dividend income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Net result from financial instruments at fair value through profit or loss |
16 | 28 | 24 | 14 | 10 | 13 | 20 | - |
| Net realised result from available-for-sale assets | 7 | 6 | 0 | 4 | 8 | 0 | 0 | - |
| Net fee and commission income | 47 | 43 | 45 | 49 | 45 | 48 | 50 | - |
| Other net income | 3 | 2 | 8 | -4 | 2 | 8 | 3 | - |
| Total income | 325 | 330 | 330 | 305 | 303 | 312 | 307 | - |
| Operating expenses | -158 | -156 | -150 | -158 | -145 | -148 | -144 | - |
| Impairment | -20 | -7 | -6 | -16 | -2 | -2 | -14 | - |
| on loans and receivables | -20 | -8 | -6 | -13 | -2 | -2 | -14 | - |
| on available-for-sale assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| on goodwill Other |
0 0 |
0 0 |
0 0 |
0 -3 |
0 0 |
0 0 |
0 0 |
- - |
| Share in results of associated companies and joint | ||||||||
| ventures | 7 | 7 | 8 | 6 | 6 | 6 | 5 | - |
| Result before tax | 155 | 174 | 183 | 136 | 163 | 167 | 154 | - |
| Income tax expense | -22 | -28 | -26 | -17 | -25 | -28 | -24 | - |
| Result after tax | 132 | 146 | 157 | 119 | 138 | 140 | 130 | - |
| attributable to minority interests | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| attributable to equity holders of the parent | 132 | 146 | 157 | 119 | 138 | 140 | 130 | - |
| Banking | 128 | 143 | 150 | 109 | 132 | 133 | 123 | - |
| Insurance | 5 | 3 | 7 | 10 | 6 | 7 | 7 | - |
| Risk-weighted assets banking (end of period, Basel III) | 12 234 | 13 119 | 13 164 | 12 563 | 12 618 | 12 453 | 12 148 | - |
| Required capital insurance (end of period, Solvency I) | 72 | 72 | 73 | 69 | 69 | 68 | 67 | - |
| Allocated capital (end of period) | 1 349 | 1 438 | 1 444 | 1 378 | 1 445 | 1 426 | 1 393 | - |
| Return on allocated capital (ROAC) | 38% | 44% | 43% | 35% | 38% | 39% | 36% | - |
| Cost/income ratio, banking | 48% | 46% | 45% | 52% | 47% | 47% | 46% | - |
| Combined ratio, non-life insurance | 99% | 104% | 97% | 84% | 94% | 92% | 95% | - |
| Net interest margin, banking | 3.31% | 3.33% | 3.28% | 3.09% | 3.29% | 3.20% | 3.12% | - |
Note that the 2013 reference figures have been adjusted slightly following the application of the FRS 11 standard. This standard stipulates that joint ventures must be accounted for using the equity method instead of (until now) the proportionate consolidation method. For KBC, this applies to ČMSS, a joint venture of ČSOB in the Czech Republic. This change does not affect the net result, but has an impact on various items in the consolidated income statement.
In the quarter under review, the Czech Republic Business Unit posted a net result of 130 million, somewhat below the 139-million average for the four preceding quarters. Compared with the previous quarter, the results for 3Q2014 featured (on a comparable basis) flat net interest income, lower net fee and commission income, a lack of realised gains on the sale of financial assets, higher net results from financial instruments, a lower level of other income, a solid non-life combined ratio and increased sales of unit-linked life insurance products. Costs declined slightly and loan loss impairment charges were up on the unsustainably low level recorded in the previous quarter. Banking activities accounted for 95% of the net result in the quarter under review, and insurance activities for 5%.
Net interest income generated in this business unit amounted to 211 million in the quarter under review. Excluding the effect of the exchange rate (the Czech koruna weakened only marginally during 3Q2014, but has depreciated by 6% on its year-earlier level) and certain changes in the scope of consolidation (mainly the exclusion of a pension fund and the inclusion of Patria Corporate Finance and Patria Online), net interest income was virtually flat quarter-on-quarter but up 1% year-on-year. In both cases, net interest income remained under pressure due to the lower reinvestment yield, though this effect was offset in part by volume growth (loans and current accounts, among other things) and lower interest rates on saving accounts.
Disregarding the FX effect, the group's Czech loan book (16 billion in 'Loans and advances to customers, excluding reverse repos' at 30 September 2014) was up 2% quarter-on-quarter and 6% year-on-year. The latter performance was driven mainly by the growth of mortgage loans and to a lesser extent by loans to SMEs and corporations. The deposit base (21 billion in 'Deposits from customers and debt certificates, excluding repos') was up 1% quarter-on-quarter and 8% year-on-year.
The overall net interest margin of the ČSOB group in the Czech Republic amounted to 312 basis points in the quarter under review, i.e. down 8 and 16 basis points, respectively, on the previous and year-earlier quarters.
In the non-life business, premium income stood at 42 million, up 5% quarter-on-quarter and 4% year-on-year (disregarding the FX impact in both cases) thanks mainly to improved sales in the 'motor retail' and 'households' segments. At 23 million, technical charges were up 11% on 2Q2014 (impacted by one large MTPL claim, among other things), but down 6% on 3Q2013 (disregarding the FX impact in both cases). When account is also taken of the impact of reinsurance, earned premiums less technical charges improved slightly on their 2Q2014 (+3%) and 3Q2013 (+2%) levels. The combined ratio for the quarter under review stood at a good 95%. Year-to-date, the 9M2014 combined ratio came to 94%, an improvement on the FY2013 figure of 96%.
In the life business, sales amounted to 51 million in the quarter under review, up on the previous quarter (41 million) and roughly in line with the year-earlier quarter (53 million). The quarter-on-quarter increase was due entirely to higher sales of unit-linked life insurance products (Maximal Invest Life products) and as a consequence, these products accounted for close to three-quarters of life sales in the quarter under review. At the end of September 2014, the outstanding life reserves (including the liabilities under unit-linked products) in this business unit stood at 1 billion, down 11% year-on-year.
Note that the life and non-life insurance results described above only relate to premiums and technical charges. The insurance bottom line is also clearly impacted by investment income, costs, taxes, etc., all of which are analysed from a group perspective (i.e. banking and insurance together) in this section.
Net fee and commission income stood at 50 million in the quarter under review, down 6% compared to the previous quarter, but up 6% on its 3Q2013 level (disregarding FX effects and the change in the consolidation scope in both cases). Quarter-on-quarter, the decline was attributable mainly to lower fee income from financial markets activities, somewhat lower account fees and a drop in fees related to mortgage loans, partly offset by higher entry fees on mutual funds. Year-on-year, the increase was accounted for primarily by higher fees in relation to mutual funds and higher loan fees, among other things. Total assets under management in this business unit came to roughly 7 billion at quarter-end, up 6% quarter-on-quarter (5% owing to net entries and 1% due to a positive price effect) and up 14% year-on-year (11% due to net entries and 2% owing to a positive price effect).
Trading and fair value income (recorded under 'Net result from financial instruments at fair value through profit or loss') came to 20 million, higher than the average figure of 15 million for the four preceding quarters (quarter-on-
quarter, the increase is mainly related to less negative marked-to-market valuation of ALM derivatives and improved marked value adjustments). In the quarter under review, there were no realised gains from the sale of available-for-sale assets, as opposed to an average 3 million for the last four quarters. Other net income totalled 3 million in the quarter under review, more or less in line with the 4 million average for the four preceding quarters.
The operating expenses of this business unit came to 144 million, a 2% decrease (disregarding FX effects) compared with 2Q2014, thanks mainly to lower ICT, pension and facilities expenses, partly offset by higher staff expenses. Compared to 3Q2013, costs increased by 3% (disregarding FX effects), due primarily to higher staff expenses and ICT costs.
Consequently, the cost/income ratio of the Czech Republic Business Unit came to a good 46%, more or less comparable to the previous quarters, and as a consequence the resultant 9M2014 year-to-date ratio came to 47%, the same level as in FY2013.
Impairment on loans and receivables (loan loss provisions) stood at what is still a favourable 14 million in the quarter under review, but was clearly up on the very low (and unsustainable) 2 million recorded in the previous quarter and up on the 6 million recorded in 3Q2013. The quarter under review included 5 million in impairment charges related to forbearance, whereas the reference quarters benefited from loan loss provision releases. As a result, the 9M2014 credit cost ratio of this business unit amounted to a fine 13 basis points, a further improvement on what was already a good 26 basis points for FY2013. At the end of 3Q2014, some 4.1% of the
Czech loan book was impaired, an improvement on the 4.3% recorded at the start of the year. Impaired loans that are more than 90 days overdue (referred to as 'non-performing loans' in previous reports) accounted for 3.0%, as opposed to 3.1% at the start of the year.
There were no impairment charges on assets other than loans and receivables in the quarter under review.
The International Markets Business Unit mainly includes the activities in the other (i.e. non-Czech) Central and Eastern European core markets (ČSOB Bank and ČSOB Poist'ovňa in Slovakia, K&H Bank and K&H Insurance in Hungary, CIBank and DZI Insurance in Bulgaria) and KBC Bank Ireland.
| Income statement, International Markets Business Unit (in millions of EUR) |
1Q2013 | 2Q2013 | 3Q2013 | 4Q2013 | 1Q2014 | 2Q2014 | 3Q2014 | 4Q2014 |
|---|---|---|---|---|---|---|---|---|
| Net interest income | 155 | 160 | 163 | 155 | 160 | 173 | 175 | - |
| Non-life insurance (before reinsurance) | 21 | 19 | 20 | 20 | 19 | 19 | 8 | - |
| Earned premiums | 39 | 38 | 39 | 39 | 37 | 38 | 39 | - |
| Technical charges | -18 | -20 | -19 | -18 | -18 | -19 | -31 | - |
| Life insurance (before reinsurance) | 2 | 0 | 0 | 2 | 1 | 4 | 4 | - |
| Earned premiums | 25 | 20 | 18 | 19 | 22 | 22 | 21 | - |
| Technical charges | -23 | -21 | -18 | -17 | -21 | -19 | -17 | - |
| Ceded reinsurance result | -2 | -2 | -2 | -4 | -2 | -2 | 7 | - |
| Dividend income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Net result from financial instruments at fair value through profit or loss |
21 | 22 | 29 | 17 | 25 | 17 | 17 | - |
| Net realised result from available-for-sale assets | 2 | 8 | 2 | 1 | 2 | 7 | 6 | - |
| Net fee and commission income | 41 | 45 | 50 | 68 | 49 | 51 | 54 | - |
| Other net income | 2 | 19 | 1 | -2 | 0 | -227 | 3 | - |
| Total income | 242 | 272 | 262 | 258 | 253 | 44 | 273 | - |
| Operating expenses | -210 | -176 | -156 | -173 | -216 | -166 | -167 | - |
| Impairment | -127 | -116 | -119 | -827 | -64 | -84 | -63 | - |
| on loans and receivables | -117 | -114 | -118 | -821 | -64 | -84 | -63 | - |
| on available-for-sale assets | -10 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| on goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| other Share in results of associated companies and joint |
-1 | -1 | 0 | -6 | 0 | -1 | 0 | - |
| ventures | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Result before tax | -95 | -19 | -12 | -742 | -27 | -207 | 43 | - |
| Income tax expense | 8 | -4 | 0 | 11 | 1 | 31 | -16 | - |
| Result after tax | -87 | -23 | -12 | -731 | -26 | -176 | 27 | - |
| attributable to minority interests | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| attributable to equity holders of the parent | -87 | -23 | -12 | -731 | -26 | -176 | 27 | - |
| Banking | -82 | -29 | -17 | -735 | -33 | -182 | 23 | - |
| Insurance | -6 | 6 | 6 | 4 | 7 | 6 | 4 | - |
| Risk-weighted assets banking (end of period, Basel III) | 16 963 | 16 356 | 16 110 | 16 247 | 18 484 | 17 506 | 18 342 | - |
| Required capital insurance (end of period, Solvency I) | 43 | 42 | 42 | 44 | 44 | 44 | 44 | - |
| Allocated capital (end of period) | 1 772 | 1 710 | 1 684 | 1 702 | 2 017 | 1 915 | 2 003 | - |
| Return on allocated capital (ROAC) | -19% | -5% | -3% | -176% | -5% | -35% | 6% | - |
| Cost/income ratio, banking | 88% | 65% | 59% | 67% | 88% | - | 60% | - |
| Combined ratio, non-life insurance | 87% | 98% | 97% | 103% | 89% | 99% | 105% | - |
| Net interest margin, banking | 2.06% | 2.10% | 2.11% | 2.07% | 2.26% | 2.46% | 2.50% | - |
In the quarter under review, the International Markets Business Unit recorded a positive net result of 27 million, a significant improvement on the negative 236-million-average for the four preceding quarters (which had been significantly affected by the additional loan loss provisions for Ireland in 4Q2013 and by the impact of the new retail loans act in Hungary in 2Q2014). Compared to the previous quarter, 3Q2014 was characterised by slightly higher net interest income and strong net fee and commission income, a stable result from financial instruments at fair value and somewhat lower realised gains on bonds and shares, a deterioration in the non-life combined ratio and lower life insurance sales. It should be noted that the previous quarter had been significantly impacted by the new Hungarian act on retail loans. Costs in 3Q2014 were flat, and loan loss provisions fell, mainly in Ireland.
Overall, the banking activities accounted for a net result of 23 million (positive results in Slovakia, Hungary and Bulgaria, but negative in Ireland), while the insurance activities accounted for a net result of 4 million.
Net interest income stood at 175 million in 3Q2014, up 1% on 2Q2014 and up 7% on 3Q2013. The year-on-year increase was accounted for mainly by Ireland (lower funding and allocated liquidity costs) and to a lesser extent by Hungary (improved funding structure).
The total loan portfolio of the International Markets Business Unit (21 billion in 'Loans and advances to customers, excluding reverse repos at 30 September 2014) was up slightly (0.4%) quarter-on-quarter and down 5% year-onyear. This year-on-year decline was entirely attributable to Ireland (-12%; matured and impaired loans surpassing new mortgage production and the corporate loan portfolio being deleveraged), which more than offset loan growth in Slovakia (+5%), Hungary (+3%) and Bulgaria (+17%). Customer deposits for the entire business unit (15 billion in 'Deposits from customers and debt certificates, excluding repos') increased by 2% in the quarter under review (mainly in Slovakia and Hungary), and by 1% compared to the situation a year ago (thanks mainly to the successful retail deposit campaign in Ireland).
On a weighted basis, the net interest margin of this business unit amounted to 250 basis points in the quarter under review, up 4 basis points quarter-on-quarter and 39 basis points year-on-year. The net interest margin in 3Q2014 amounted to 315 basis points in Slovakia (down both quarter-on-quarter and year-on-year), 411 basis points in Hungary (up both quarter-on-quarter and year-on-year), 485 basis points in Bulgaria (up quarter-onquarter but down year-on-year), and 121 basis points in Ireland (up both quarter-on-quarter and year-on-year).
In the non-life business, earned insurance premiums in the quarter under review (which relate solely to Hungary, Slovakia and Bulgaria, as there are no direct insurance activities in Ireland) amounted to 39 million, up 2% on the quarter-earlier figure and down 2% compared to 3Q2013. At 31 million, technical insurance charges in the non-life segment were up significantly (by 59% and 57%) on the previous and year-earlier quarters, respectively, due mainly to Bulgaria (bad weather conditions; largely reinsured). Overall, the non-life combined ratio for the quarter under review deteriorated to 105%, compared with 99% in 2Q2014. Consequently, the ratio came to 97% for 9M2014, compared to the 95% recorded for FY2013. The combined ratio for 9M2014 breaks down into 93% for Hungary, 89% for Slovakia and 103% for Bulgaria.
Life sales, including insurance products not recognised as earned premiums under IFRS, amounted to 25 million in the quarter under review, down 7 million on the level recorded in the previous quarter (due primarily to a decline in Hungary) but up some 4 million on 3Q2013 (increase in Slovakia and Hungary). For the business unit as a whole, sales of unit-linked products accounted for 56% of total life insurance sales in the quarter under review, and interest-guaranteed products for the remainder. At the end of September 2014, the business unit's outstanding life reserves (including the liabilities under unit-linked products) stood at 0.5 billion, up 5% year-onyear.
The other income components totalled 80 million in the quarter under review. This included net fee and commission income of 54 million, up 6% on the previous quarter (increases in every country) and 9% on 3Q2013 (increases in Hungary and Slovakia). Trading and fair value income (recorded under 'Net result from financial instruments at fair value through profit or loss') came to 17 million, down on the average figure of 22 million for the four preceding quarters. The current quarter includes a negative impact of 7 million related to the marked-tomarket valuation of ALM derivatives (versus -7 million in 2Q2014 and no impact in 3Q2013). The net realised result from available-for-sale financial assets amounted to 6 million, and other net income to 3 million, as opposed to -227 million in the previous quarter. That quarter had included the impact of a 231-million-pre-tax provision for
the new Hungarian act on retail loans, i.e. the so-called 'Resolution of certain issues related to the Supreme Court's (Curia) uniformity decision on consumer loan agreements concluded by financial institutions'.
Operating expenses in the quarter under review amounted to 167 million, flat on the previous quarter and up 7% compared to a year ago. This increase was accounted for almost entirely by Ireland (an increasing number of FTEs due to recruitment related to the retail programme and for the arrears support unit, among other things) and by Slovakia (higher staff expenses, ICT and marketing costs, etc.).
As a consequence, the cost/income ratio for the business unit as a whole stood at 60% in the quarter under review, or 100% for the first nine months of the year (the latter figure is relatively high, as the second quarter had been hit by the impact of the new retail loans act in Hungary), compared to 69% for FY2013. Excluding the main exceptional items, the 'sustainable' ratio would have been 66% in 9M2014, as opposed to 68% in FY2013. The 9M2014 cost/income ratio of 100% breaks down as follows per country: 97% for Ireland, 62% for Slovakia, 158% for Hungary (including the impact of the new retail loans act in 2Q2014; 62% on a sustainable basis) and 63% for Bulgaria.
Impairment on loans and receivables (loan loss provisions) amounted to 63 million, an improvement on the 84 million recorded in 2Q2014 and the 118 million recorded in 3Q2013. The 3Q2014 figure includes 47 million for Ireland (lower than the 62 million recorded in 2Q2014 and the 98 million recorded in 3Q2013), and 3 million in loan loss provisions for Slovakia, 11 million for Hungary and 2 million for Bulgaria.
Consequently, the 9M2014 credit cost ratio for the entire business unit improved to 109 basis points, down from a high 448 basis points for FY2013. Broken down by country, it was 140 basis points for Ireland (672 basis points in FY2013), 92 basis points for Hungary (150 basis points in FY2013), 34 basis points for Slovakia (60 basis points in FY2013) and 119 basis points for Bulgaria (119 basis points for FY2013). At the end of 3Q2014, some 35% of the business unit's loan book was impaired, slightly up on the 33% recorded at the start of the year. Impaired loans that are more than 90 days overdue (referred to as 'non-performing loans' in previous reports) account for 20%, as opposed to 19.2% at the start of the year. The business unit's 3Q2014 figure continues to be impacted by the high impaired loans ratio for Ireland (impaired loans: 53%, 28% of which more than 90 days overdue).
There were no impairment charges on assets other than on loans and receivables for this business unit in the quarter under review.
The net result of the International Markets Business Unit (27 million) breaks down as follows: 20 million for Slovakia, 39 million for Hungary, 3 million for Bulgaria and -36 million for Ireland. A detailed results table and brief comments per country are provided below.
| IRELAND Income statement (in millions of EUR) |
1Q2013 | 2Q2013 | 3Q2013 | 4Q2013 | 1Q2014 | 2Q2014 | 3Q2014 | 4Q2014 |
|---|---|---|---|---|---|---|---|---|
| Net interest income | 35 | 33 | 32 | 24 | 31 | 38 | 39 | - |
| Non-life insurance (before reinsurance) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Earned premiums | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Technical charges | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Life insurance (before reinsurance) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Earned premiums | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Technical charges | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Ceded reinsurance result | 0 | 0 | 0 | 0 | 0 | 0 | - | |
| Dividend income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Net result from financial instruments at fair value through profit or loss |
-3 | 0 | 0 | -3 | 0 | -6 | -2 | - |
| Net realised result from available-for-sale assets | 0 | 1 | 0 | 0 | 0 | 0 | 0 | - |
| Net fee and commission income | -1 | -2 | 0 | -2 | -1 | -1 | 0 | - |
| Other net income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Total income | 32 | 31 | 32 | 19 | 30 | 31 | 37 | - |
| Operating expenses | -21 | -22 | -25 | -35 | -29 | -33 | -33 | - |
| Impairment | -99 | -88 | -98 | -773 | -48 | -62 | -47 | - |
| on loans and receivables | -99 | -88 | -98 | -773 | -48 | -62 | -47 | - |
| on available-for-sale assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| on goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Other Share in results of associated companies and joint |
0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| ventures | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Result before tax | -88 | -79 | -92 | -789 | -47 | -64 | -43 | - |
| Income tax expense | 11 | 10 | 11 | 23 | 7 | 6 | 7 | - |
| Result after tax | -77 | -69 | -80 | -766 | -40 | -57 | -36 | - |
| attributable to minority interests | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| attributable to equity holders of the parent | -77 | -69 | -80 | -766 | -40 | -57 | -36 | - |
| Banking | -77 | -69 | -80 | -766 | -40 | -57 | -36 | - |
| Insurance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Risk-weighted assets banking (end of period, Basel III) | 7 653 | 7 248 | 6 952 | 7 357 | 6 558 | 5 650 | 5 641 | - |
| Required capital insurance (end of period, Solvency I) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Allocated capital (end of period) | 765 | 725 | 695 | 736 | 689 | 593 | 592 | - |
| Return on allocated capital (ROAC) | -39% | -36% | -45% | -444% | -22% | -34% | -25% | - |
| Cost/income ratio, banking | 65% | 69% | 79% | 183% | 98% | 106% | 88% | - |
| Combined ratio, non-life insurance | - | - | - | - | - | - | - | - |
The net result in 3Q2014 was -36 million euros, compared to an average figure of -236 million for the four preceding quarters (clearly impacted by the high loss recorded in 4Q2013).
Total income (37 million) increased by 20% quarter-on-quarter, due mainly to slightly higher net interest income, and the fact that the previous quarter had been negatively impacted by a one-off item.
Costs (33 million) were flat compared with the previous quarter. The 9M2014 cost/income ratio stood at 97%, compared with 90% for FY2013.
Loan loss impairment (47 million) was lower than the 62 million recorded in 2Q2014. The 3Q2014 figure breaks down into 31 million for corporate loans (up slightly on 2Q2014) and 16 million for retail loans (down significantly on 2Q2014). The credit cost ratio amounted to 140 basis points in 9M2014.
| HUNGARY | 1Q2013 | 2Q2013 | 3Q2013 | 4Q2013 | 1Q2014 | 2Q2014 | 3Q2014 | 4Q2014 |
|---|---|---|---|---|---|---|---|---|
| Income statement (in millions of EUR) Net interest income |
64 | 69 | 68 | 68 | 68 | 72 | 72 | - |
| Non-life insurance (before reinsurance) | 7 | 7 | 7 | 5 | 7 | 6 | 6 | - |
| Earned premiums | 14 | 15 | 16 | 14 | 13 | 14 | 14 | - |
| Technical charges | -7 | -8 | -8 | -9 | -6 | -8 | -8 | - |
| Life insurance (before reinsurance) | -1 | -4 | -3 | -2 | -2 | -1 | 0 | - |
| Earned premiums | 3 | 3 | 3 | 4 | 3 | 4 | 3 | - |
| Technical charges | -5 | -7 | -7 | -5 | -6 | -5 | -3 | - |
| Ceded reinsurance result | 0 | -1 | -1 | -1 | -1 | -1 | 0 | - |
| Dividend income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Net result from financial instruments at fair value through profit or loss |
18 | 18 | 25 | 16 | 20 | 20 | 14 | - |
| Net realised result from available-for-sale assets | 2 | 5 | 0 | 0 | 1 | 7 | 6 | - |
| Net fee and commission income | 30 | 34 | 37 | 58 | 38 | 40 | 41 | - |
| Other net income | 2 | 13 | 0 | -4 | 1 | -228 | 1 | - |
| Total income | 121 | 141 | 134 | 141 | 132 | -84 | 140 | - |
| Operating expenses | -130 | -97 | -73 | -78 | -128 | -74 | -73 | - |
| Impairment | -11 | -11 | -13 | -43 | -12 | -13 | -11 | - |
| on loans and receivables | -10 | -10 | -12 | -43 | -11 | -13 | -11 | - |
| on available-for-sale assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| on goodwill Other |
0 -1 |
0 -1 |
0 0 |
0 0 |
0 0 |
0 -1 |
0 0 |
- - |
| Share in results of associated companies and joint ventures |
0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Result before tax | -20 | 33 | 48 | 20 | -8 | -171 | 56 | - |
| Income tax expense | 1 | -7 | -5 | -4 | 0 | 32 | -17 | - |
| Result after tax | -19 | 26 | 43 | 16 | -8 | -139 | 39 | - |
| attributable to minority interests | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| attributable to equity holders of the parent | -19 | 26 | 43 | 16 | -8 | -139 | 39 | - |
| Banking | -22 | 24 | 41 | 15 | -11 | -141 | 37 | - |
| Insurance | 3 | 2 | 2 | 1 | 3 | 2 | 2 | - |
| Risk-weighted assets banking (end of period, Basel III) | 4 919 | 4 759 | 4 827 | 4 434 | 7 562 | 7 440 | 8 263 | - |
| Required capital insurance (end of period, Solvency I) | 13 | 13 | 12 | 14 | 14 | 14 | 14 | - |
| Allocated capital (end of period) | 515 | 499 | 504 | 469 | 818 | 806 | 892 | - |
| Return on allocated capital (ROAC) | -14% | 20% | 34% | 13% | -5% | -69% | 18% | - |
| Cost/income ratio, banking | 112% | 70% | 55% | 54% | 100% | - | 52% | - |
| Combined ratio, non-life insurance | 82% | 100% | 95% | 120% | 82% | 102% | 100% | - |
The net result in 3Q2014 was a positive 39 million euros, up on the negative 22 million average for the four preceding quarters (which included a large provision in 2Q1014 for the new Hungarian act on retail loans).
| SLOVAKIA | 1Q2013 | 2Q2013 | 3Q2013 | 4Q2013 | 1Q2014 | 2Q2014 | 3Q2014 | 4Q2014 |
|---|---|---|---|---|---|---|---|---|
| Income statement (in millions of EUR) Net interest income |
46 | 49 | 52 | 52 | 51 | 53 | 53 | - |
| Non-life insurance (before reinsurance) | 5 | 5 | 6 | 6 | 4 | 5 | 5 | - |
| Earned premiums | 6 | 6 | 7 | 7 | 7 | 7 | 7 | - |
| Technical charges | -1 | -1 | -1 | 0 | -2 | -2 | -3 | - |
| Life insurance (before reinsurance) | 3 | 2 | 2 | 3 | 3 | 3 | 3 | - |
| Earned premiums | 16 | 14 | 12 | 12 | 13 | 15 | 14 | - |
| Technical charges | -14 | -11 | -9 | -9 | -11 | -12 | -11 | - |
| Ceded reinsurance result | 0 | 0 | 0 | -1 | 0 | 0 | 0 | - |
| Dividend income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Net result from financial instruments at fair value through profit or loss |
6 | 4 | 5 | 4 | 4 | 3 | 3 | - |
| Net realised result from available-for-sale assets | 0 | 3 | 0 | 0 | 1 | 0 | 0 | - |
| Net fee and commission income | 11 | 11 | 11 | 11 | 11 | 11 | 12 | - |
| Other net income | 2 | 6 | 1 | 1 | -1 | 1 | 1 | - |
| Total income | 72 | 81 | 76 | 76 | 73 | 76 | 76 | - |
| Operating expenses | -46 | -44 | -44 | -46 | -46 | -45 | -47 | - |
| Impairment | -4 | -15 | -7 | -5 | -4 | -6 | -3 | - |
| on loans and receivables | -4 | -14 | -7 | -2 | -4 | -6 | -3 | - |
| on available-for-sale assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| on goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| other Share in results of associated companies and joint |
0 | 0 | 0 | -3 | 0 | 0 | 0 | - |
| ventures | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Result before tax | 23 | 23 | 25 | 25 | 23 | 24 | 26 | - |
| Income tax expense | -5 | -6 | -6 | -8 | -6 | -7 | -6 | - |
| Result after tax | 17 | 16 | 19 | 17 | 18 | 17 | 20 | - |
| attributable to minority interests | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| attributable to equity holders of the parent | 17 | 16 | 19 | 17 | 18 | 17 | 20 | - |
| Banking | 15 | 14 | 17 | 15 | 15 | 15 | 18 | - |
| Insurance | 3 | 2 | 3 | 2 | 3 | 2 | 2 | - |
| Risk-weighted assets banking (end of period, Basel III) | 3 780 | 3 715 | 3 689 | 3 776 | 3 725 | 3 772 | 3 745 | - |
| Required capital insurance (end of period, Solvency I) | 15 | 15 | 15 | 15 | 15 | 15 | 15 | - |
| Allocated capital (end of period) | 403 | 397 | 395 | 404 | 417 | 422 | 419 | - |
| Return on allocated capital (ROAC) | 17% | 16% | 19% | 17% | 17% | 17% | 19% | - |
| Cost/income ratio, banking | 64% | 54% | 58% | 61% | 64% | 60% | 62% | - |
| Combined ratio, non-life insurance | 65% | 77% | 81% | 83% | 82% | 89% | 97% | - |
The net result in 3Q2014 totalled 20 million euros, somewhat higher than the 18 million average for the four preceding quarters.
Total income (76 million) was roughly flat quarter-on-quarter, with net fee and commission income up and only minor changes occurring in the other income lines. The 9M2014 combined ratio for non-life insurance stood at 89%, compared with 76% for FY2013. Life sales (including unit-linked products) were virtually unchanged on their level for 2Q2014, with unit-linked products accounting for two-thirds of total life sales.
Costs (47 million) were up 4% quarter-on-quarter, owing mainly to higher staff costs and higher ICT expenses. The 9M2014 cost/income ratio stood at 62%, as opposed to 59% for FY2013.
Loan loss impairment charges (3 million) were at a modest level in the quarter under review, down 3 million on the previous quarter. The credit cost ratio amounted to 34 basis points in 9M2014.
| BULGARIA Income statement (in millions of EUR) |
1Q2013 | 2Q2013 | 3Q2013 | 4Q2013 | 1Q2014 | 2Q2014 | 3Q2014 | 4Q2014 |
|---|---|---|---|---|---|---|---|---|
| Net interest income | 10 | 10 | 10 | 11 | 10 | 10 | 11 | - |
| Non-life insurance (before reinsurance) | 8 | 7 | 7 | 9 | 8 | 8 | -3 | - |
| Earned premiums | 18 | 18 | 17 | 18 | 17 | 18 | 18 | - |
| Technical charges | -10 | -11 | -10 | -9 | -10 | -10 | -20 | - |
| Life insurance (before reinsurance) | 1 | 1 | 1 | 1 | 1 | 1 | 1 | - |
| Earned premiums | 5 | 3 | 3 | 4 | 5 | 4 | 3 | - |
| Technical charges | -4 | -2 | -2 | -3 | -4 | -2 | -2 | - |
| Ceded reinsurance result | -1 | -1 | -1 | -1 | -1 | -1 | 8 | - |
| Dividend income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Net result from financial instruments at fair value through profit or loss |
0 | 0 | 0 | 0 | 0 | 0 | 1 | - |
| Net realised result from available-for-sale assets | 1 | 0 | 1 | 1 | 0 | 0 | 0 | - |
| Net fee and commission income | 0 | 0 | 1 | 0 | 0 | 0 | 1 | - |
| Other net income | -2 | 1 | 0 | 0 | 0 | 0 | 0 | - |
| Total income | 16 | 18 | 20 | 21 | 18 | 19 | 19 | - |
| Operating expenses | -13 | -13 | -13 | -14 | -12 | -13 | -13 | - |
| Impairment | -13 | -2 | -1 | -6 | -1 | -3 | -2 | - |
| on loans and receivables | -4 | -2 | -1 | -2 | -1 | -3 | -2 | - |
| on available-for-sale assets | -10 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| on goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Other Share in results of associated companies and joint |
0 | 0 | 0 | -3 | 0 | 0 | 0 | - |
| ventures | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Result before tax | -10 | 4 | 6 | 1 | 5 | 3 | 3 | - |
| Income tax expense | 1 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Result after tax | -9 | 3 | 6 | 1 | 5 | 3 | 3 | - |
| attributable to minority interests | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| attributable to equity holders of the parent | -9 | 3 | 6 | 1 | 5 | 3 | 3 | - |
| Banking | 2 | 2 | 5 | 0 | 4 | 1 | 3 | - |
| Insurance | -11 | 1 | 1 | 1 | 1 | 2 | 0 | - |
| Risk-weighted assets banking (end of period, Basel III) | 595 | 620 | 627 | 668 | 626 | 632 | 680 | - |
| Required capital insurance (end of period, Solvency I) | 15 | 15 | 15 | 15 | 15 | 15 | 15 | - |
| Allocated capital (end of period) | 86 | 88 | 88 | 93 | 92 | 92 | 98 | - |
| Return on allocated capital (ROAC) | -40% | 16% | 27% | 5% | 21% | 13% | 15% | - |
| Cost/income ratio, banking | 57% | 67% | 61% | 61% | 64% | 65% | 60% | - |
| Combined ratio, non-life insurance | 101% | 103% | 104% | 97% | 99% | 99% | 112% | - |
The net result in 3Q2014 came to 3 million, down slightly on the 4 million average for the four preceding quarters.
Total income (19 million) was down 3% on the previous quarter. Whereas net interest income and net fee and commission income increased, the non-life insurance technical result fell due to higher claims (weather related), but was largely offset by reinsurance. Consequently, the 9M214 non-life combined ratio amounted to 103%, compared with 101% for FY2013. Total life insurance sales were down roughly a quarter on their level for 2Q2014.
Costs (13 million) were more or less flat quarter-on-quarter. The 9M2014 cost/income ratio stood at 63%, compared with 61% for FY2013.
Loan loss impairment charges stood at 2 million, down on the 3 million recorded in 2Q2014. The credit cost ratio amounted to 119 basis points in 9M2014.
The Group Centre includes the operating expenses of the group's holding-company activities, certain capital and liquidity management-related costs, costs related to the holding of participations, the results of the remaining companies or activities that are earmarked for divestment or are in run-down, and the elimination of intersegment transactions. It also includes results related to the legacy businesses (CDOs, divestment results) and the valuation of own credit risk.
| Income statement, Group Centre (in millions of EUR) |
1Q2013 | 2Q2013 | 3Q2013 | 4Q2013 | 1Q2014 | 2Q2014 | 3Q2014 | 4Q2014 |
|---|---|---|---|---|---|---|---|---|
| Adjusted net result (i.e. excluding legacy and own credit risk impact) |
||||||||
| Net interest income | -24 | -57 | -63 | -52 | -73 | -43 | -10 | - |
| Non-life insurance (before reinsurance) | -4 | -3 | -3 | -5 | -4 | -3 | -1 | - |
| Earned premiums | -8 | -4 | -3 | -5 | -5 | -4 | -4 | - |
| Technical charges | 4 | 1 | 1 | 0 | 1 | 0 | 3 | - |
| Life insurance (before reinsurance) | 0 | 1 | 0 | 1 | 0 | 0 | 0 | - |
| Earned premiums | 4 | 5 | 5 | 5 | 0 | 0 | 0 | - |
| Technical charges | -3 | -3 | -5 | -4 | 0 | 0 | 0 | - |
| Ceded reinsurance result | 1 | 0 | 2 | 2 | 3 | 2 | 0 | - |
| Dividend income | 0 | 0 | 0 | 0 | 0 | 1 | 0 | - |
| Net result from financial instruments at fair value through profit or loss |
45 | 4 | 10 | 3 | 2 | 12 | -14 | - |
| Net realised result from available-for-sale assets | 2 | 1 | 0 | 9 | -1 | 9 | 3 | - |
| Net fee and commission income | 2 | 10 | 5 | 7 | 7 | 6 | 4 | - |
| Other net income | 5 | -2 | 18 | 0 | 8 | -9 | 0 | - |
| Total income | 28 | -44 | -30 | -36 | -59 | -24 | -19 | - |
| Operating expenses | -79 | -39 | -33 | -61 | -49 | -45 | -25 | - |
| Impairment | -46 | -12 | -18 | -46 | -3 | -11 | -25 | - |
| on loans and receivables | -18 | -11 | -17 | -40 | -3 | -11 | -24 | - |
| on available-for-sale assets | -1 | -1 | -1 | -1 | 0 | -1 | 1 | - |
| on goodwill Other |
-7 -20 |
0 0 |
0 0 |
0 -5 |
0 0 |
0 0 |
0 0 |
- - |
| Share in results of associated companies and joint ventures |
0 | 0 | 0 | 0 | 1 | 1 | 1 | - |
| Result before tax | -97 | -95 | -81 | -143 | -110 | -80 | -68 | - |
| Income tax expense | 29 | 42 | 6 | 42 | 34 | 21 | 4 | - |
| Result after tax | -68 | -53 | -75 | -101 | -75 | -59 | -64 | - |
| attributable to minority interests | 3 | 4 | 4 | 4 | 0 | 0 | 0 | - |
| attributable to equity holders of the parent | -71 | -56 | -79 | -104 | -75 | -59 | -64 | - |
| Banking | 17 | -44 | -49 | -60 | -46 | -25 | -40 | - |
| Insurance | -11 | -1 | -7 | -3 | -1 | -2 | -3 | - |
| Group | -78 | -12 | -23 | -41 | -28 | -32 | -21 | - |
| Legacy – gains/losses on CDOs | 165 | 180 | 34 | 65 | 16 | 30 | -24 | - |
| Legacy – divestments | 22 | -128 | -231 | -10 | -9 | 8 | 132 | - |
| MTM of own credit risk | -26 | -20 | 12 | -9 | 2 | -8 | 6 | - |
| Net result | 90 | -24 | -264 | -58 | -65 | -30 | 50 | |
| Risk-weighted assets banking (end of period, Basel III) | 16 813 | 13 141 | 12 189 | 11 031 | 11 145 | 11 814 | 7 256 | - |
| Risk-weighted assets, insurance (end of period, Basel III Danish compromise) |
11 068 | 11 068 | 11 068 | 11 068 | 11 068 | 11 068 | 11 068 | - |
| Required capital insurance (end of period, Solvency I) | 16 | 15 | 9 | 4 | 2 | 2 | 2 | - |
| Allocated capital (end of period) | 1 709 | 1 341 | 1 234 | 1 111 | 1 174 | 1 244 | 766 | - |
The Group Centre's net result amounted to 50 million in 3Q2014. As stated earlier, this entity includes not only a number of group items and the results of companies earmarked for divestment, but also the impact of the legacy business (CDOs, divestments) and the valuation of own credit risk. Excluding the legacy business and own credit risk impact, the adjusted net result amounted to -64 million in 3Q2014.
Following the run-down of the remaining legacy CDO portfolio, the net impact of this legacy item amounted to a limited -24 million (mainly related to the collapse of the last two CDOs in portfolio). The impact of the legacy divestments came to a positive 132 million, the largest part of which related to Antwerp Diamond Bank (due to the fact that the previously agreed sale did not go through and was replaced by a run-down of activities, previously booked impairments could be reversed). The impact of the marked-to-market valuation of own credit risk (changes in the fair value of own debt instruments) was limited in the quarter under review (a positive 6 million,versus -8 million in the previous quarter), owing primarily to credit spreads widening on KBC (Ifima) subordinated debt.
KBC Group Consolidated financial statements according to IFRS 3Q 2014 and 9M 2014
| In millions of EUR | Note | 3Q 2013 | 2Q 2014 | 3Q 2014 | 9M 2013 | 9M 2014 |
|---|---|---|---|---|---|---|
| Net interest income | 3 | 1 014 | 1 056 | 1 120 | 3 069 | 3 185 |
| Interest income | 3 | 2 037 | 1 971 | 2 010 | 6 276 | 5 911 |
| Interest expense | 3 | - 1 023 | - 915 | - 890 | - 3 207 | - 2 726 |
| Non-life insurance before reinsurance | 9 | 145 | 102 | 139 | 409 | 389 |
| Earned premiums Non-life | 11 | 321 | 315 | 321 | 942 | 944 |
| Technical charges Non-life | 9 | - 176 | - 214 | - 183 | - 533 | - 555 |
| Life insurance before reinsurance | 9 | - 63 | - 56 | - 57 | - 185 | - 171 |
| Earned premiums Life | 10 | 238 | 297 | 299 | 750 | 904 |
| Technical charges Life | 9 | - 302 | - 353 | - 355 | - 936 | - 1 075 |
| Ceded reinsurance result | 9 | 1 | 19 | 4 | 2 | 6 |
| Dividend income | 4 | 14 | 24 | 9 | 39 | 47 |
| Net result from financial instruments at fair value through profit or loss | 5 | 223 | 44 | 34 | 962 | 118 |
| Net realised result from available-for-sale assets | 6 | 34 | 49 | 28 | 223 | 128 |
| Net fee and commission income | 7 | 337 | 387 | 402 | 1 107 | 1 163 |
| Fee and commission income | 7 | 507 | 533 | 579 | 1 704 | 1 668 |
| Fee and commission expense | 7 | - 170 | - 147 | - 177 | - 596 | - 505 |
| Net other income | 8 | 51 | - 99 | 73 | 107 | 26 |
| TOTAL INCOME | 1 754 | 1 526 | 1 752 | 5 733 | 4 892 | |
| Operating expenses | 12 | - 918 | - 933 | - 923 | - 2 875 | - 2 829 |
| Staff expenses | 12 | - 584 | - 559 | - 559 | - 1 754 | - 1 675 |
| General administrative expenses | 12 | - 267 | - 311 | - 298 | - 919 | - 962 |
| Depreciation and amortisation of fixed assets | 12 | - 67 | - 63 | - 65 | - 202 | - 193 |
| Impairment | 14 | - 362 | - 142 | - 58 | - 987 | - 313 |
| on loans and receivables | 14 | - 230 | - 136 | - 190 | - 777 | - 429 |
| on available-for-sale assets | 14 | - 8 | - 3 | - 6 | - 24 | - 14 |
| on goodwill | 14 | 0 | 0 | 0 | - 7 | 0 |
| on other | 14 | - 125 | - 3 | 139 | - 179 | 130 |
| Share in results of associated companies and joint ventures | 15 | 9 | 7 | 6 | 24 | 19 |
| RESULT BEFORE TAX | 483 | 457 | 777 | 1 895 | 1 769 | |
| Income tax expense | 16 | - 207 | - 140 | - 186 | - 575 | - 464 |
| Net post-tax result from discontinued operations | 46 | 0 | 0 | 0 | 0 | 0 |
| RESULT AFTER TAX | 276 | 317 | 591 | 1 319 | 1 305 | |
| Attributable to minority interest | 4 | 0 | 0 | 10 | 0 | |
| of which relating to discontinued operations | 0 | 0 | 0 | 0 | 0 | |
| Attributable to equity holders of the parent | 272 | 317 | 591 | 1 309 | 1 305 | |
| of which relating to discontinued operations | 0 | 0 | 0 | 0 | 0 | |
| Earnings per share (in EUR) | 17 | |||||
| Basic | 17 | -0.75 | 0.63 | 1.28 | 1.74 | 2.35 |
| Diluted | 17 | -0.75 | 0.63 | 1.28 | 1.74 | 2.35 |
Due to the application of IFRS 11 as from 1 January 2014, the reference figures of the consolidated income statement have been restated to account for the different treatment of the joint venture ČMSS in the Czech Business Unit (from proportionate consolidation to equity method - for more information see note 1a).
| In millions of EUR | 3Q 2013 | 2Q 2014 | 3Q 2014 | 9M 2013 | 9M 2014 |
|---|---|---|---|---|---|
| RESULT AFTER TAX | 276 | 317 | 591 | 1 319 | 1 305 |
| attributable to minority interest | 4 | 0 | 0 | 10 | 0 |
| attributable to equity holders of the parent | 272 | 317 | 591 | 1 309 | 1 305 |
| Other comprehensive income - to be recycled to P&L | |||||
| Net change in revaluation reserve (AFS assets) - Equity | 41 | 18 | 6 | 34 | - 13 |
| Net change in revaluation reserve (AFS assets) - Bonds | 2 | 234 | 151 | - 290 | 552 |
| Net change in revaluation reserve (AFS assets) - Other | 0 | - 1 | 1 | 0 | 0 |
| Net change in hedging reserve (cash flow hedge) | 52 | - 192 | - 210 | 308 | - 583 |
| Net change in translation differences | - 14 | 13 | 67 | - 44 | 67 |
| Other movements | 1 | 0 | 0 | 2 | 0 |
| Other comprehensive income - not to be recycled to P&L | |||||
| Net change in defined benefit plans | 6 | - 23 | - 67 | 2 | - 110 |
| TOTAL COMPREHENSIVE INCOME | 364 | 365 | 538 | 1 332 | 1 218 |
| attributable to minority interest | 4 | 0 | 0 | 10 | 0 |
| attributable to equity holders of the parent | 360 | 365 | 538 | 1 322 | 1 217 |
| ASSETS (in millions of EUR) | Note | 31-12-2013 | 30-09-2014 |
|---|---|---|---|
| Cash and cash balances with central banks | 4 294 | 8 245 | |
| Financial assets | 18 - 26 | 222 887 | 235 087 |
| Held for trading | 16 885 | 13 032 | |
| Designated at fair value through profit or loss | 16 441 | 18 850 | |
| Available for sale | 27 307 | 30 958 | |
| Loans and receivables | 130 153 | 140 118 | |
| Held to maturity | 31 323 | 31 067 | |
| Hedging derivatives | 777 | 1 062 | |
| Reinsurers' share in technical provisions | 146 | 183 | |
| Fair value adjustments of hedged items in portfolio hedge of interest rate risk | 120 | 163 | |
| Tax assets | 1 723 | 1 779 | |
| Current tax assets | 242 | 127 | |
| Deferred tax assets | 1 481 | 1 653 | |
| Non-current assets held for sale and assets associated with disposal groups | 46 | 3 769 | 24 |
| Investments in associated companies and joint ventures | 182 | 196 | |
| Investment property | 598 | 580 | |
| Property and equipment | 2 457 | 2 254 | |
| Goodwill and other intangible assets | 1 277 | 1 266 | |
| Other assets | 1 233 | 1 834 | |
| TOTAL ASSETS | 238 686 | 251 612 |
| LIABILITIES AND EQUITY (in millions of EUR) | Note | 31-12-2013 | 30-09-2014 |
|---|---|---|---|
| Financial liabilities | 18 - 26 | 199 421 | 212 012 |
| Held for trading | 13 119 | 9 428 | |
| Designated at fair value through profit or loss | 24 931 | 28 499 | |
| Measured at amortised cost | 159 693 | 171 234 | |
| Hedging derivatives | 1 678 | 2 852 | |
| Technical provisions, before reinsurance | 18 701 | 19 065 | |
| Fair value adjustments of hedged items in portfolio hedge of interest rate risk | - 2 | 137 | |
| Tax liabilities | 518 | 717 | |
| Current tax liabilities | 109 | 144 | |
| Deferred tax liabilies | 409 | 573 | |
| Liabilities associated with disposal groups | 46 | 2 027 | 0 |
| Provisions for risks and charges | 523 | 721 | |
| Other liabilities | 2 983 | 2 722 | |
| TOTAL LIABILITIES | 224 172 | 235 375 | |
| Total equity | 39 | 14 514 | 16 237 |
| Parent shareholders' equity | 39 | 11 826 | 12 840 |
| Non-voting core-capital securities | 39 | 2 333 | 2 000 |
| Additional Tier-1 instruments included in equity | 39 | 0 | 1 400 |
| Minority interests | 354 | - 3 | |
| TOTAL LIABILITIES AND EQUITY | 238 686 | 251 612 |
Due to the application of IFRS 11 as from 1 January 2014, the reference figures of the consolidated balance sheet have been restated to account for the different treatment of the joint venture ČMSS in the Czech Business Unit (from proportionate consolidation to equity method - for more information see note 1a).
| Revaluation | Remeasurement of | Non-voting | Additional Tier-1 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Issued and paid | Share | Treasury | reserve | Hedging reserve | defined benefit | Translation | Parent share | core-capital | instruments | Minority | |||
| In millions of EUR | up share capital | premium | shares | (AFS assets) | (cashflow hedges) | obligations Reserves | differences | holders' equity | securities | included in equity | interests | Total equity | |
| 30-09-2013 | |||||||||||||
| Balance at the beginning of the period (31-12-2012) First time application IAS19 Revised |
1 450 0 |
5 388 0 |
- 1 0 |
1 263 0 |
- 834 0 |
0 - 71 |
5 192 - 11 |
- 360 0 |
12 099 - 82 |
3 500 0 |
0 0 |
362 0 |
15 961 - 82 |
| Adjusted balance at the beginning of the period | 1 450 | 5 388 | - 1 | 1 263 | - 834 | - 71 | 5 182 | - 360 | 12 017 | 3 500 | 0 | 362 | 15 879 |
| Net result for the period | 0 | 0 | 0 | 0 | 0 | 0 | 1 309 | 0 | 1 309 | 0 | 0 | 10 | 1 319 |
| Other comprehensive income for the period | 0 | 1 | 0 | - 255 | 308 | 2 | 1 | - 44 | 13 | 0 | 0 | 0 | 13 |
| Total comprehensive income | 0 | 1 | 0 | - 255 | 308 | 2 | 1 310 | - 44 | 1 322 | 0 | 0 | 10 | 1 332 |
| Dividends | 0 | 0 | 0 | 0 | 0 | 0 | - 961 | 0 | - 961 | 0 | 0 | 0 | - 961 |
| Capital increase | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Repayment of non-voting core-capital securities | 0 | 0 | 0 | 0 | 0 | 0 | - 583 | 0 | - 583 | - 1 167 | 0 | 0 | - 1 750 |
| Sales of treasury shares | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 |
| Impact business combinations | 0 | 0 | 0 | 0 | 0 | 0 | - 2 | 0 | - 2 | 0 | 0 | 0 | - 2 |
| Change in minorities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - 14 | - 14 |
| Change in scope | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 102 | 102 | 0 | 0 | - 4 | 97 |
| Total change | 0 | 1 | 1 | - 255 | 308 | 2 | - 237 | 58 | - 122 | - 1 167 | 0 | - 8 | - 1 297 |
| Balance at the end of the period | 1 450 | 5 390 | 0 | 1 008 | - 526 | - 70 | 4 945 | - 302 | 11 895 | 2 333 | 0 | 354 | 14 582 |
| of which revaluation reserve for shares | 240 | ||||||||||||
| of which revaluation reserve for bonds | 768 | ||||||||||||
| of which revaluation reserve for other assets than bonds and shares | 0 | ||||||||||||
| of which relating to non-current assets held for sale and disposal groups | 4 | 1 | 0 | - 38 | - 33 | ||||||||
| 30-09-2014 | |||||||||||||
| Balance at the beginning of the period (31-12-2013) | 1 452 | 5 404 | 0 | 1 094 | - 497 | 65 | 4 648 | - 340 | 11 826 | 2 333 | 0 | 354 | 14 514 |
| Net result for the period | 0 | 0 | 0 | 0 | 0 | 0 | 1 305 | 0 | 1 305 | 0 | 0 | 0 | 1 305 |
| Other comprehensive income for the period | 0 | 0 | 0 | 538 | - 583 | - 110 | 0 | 67 | - 88 | 0 | 0 | 0 | - 88 |
| Total comprehensive income | 0 | 0 | 0 | 538 | - 583 | - 110 | 1 305 | 67 | 1 217 | 0 | 0 | 0 | 1 218 |
| Dividends | 0 | 0 | 0 | 0 | 0 | 0 | - 28 | 0 | - 28 | 0 | 0 | 0 | - 28 |
| Capital increase | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Repayment of non-voting core-capital securities | 0 | 0 | 0 | 0 | 0 | 0 | - 167 | 0 | - 167 | - 333 | 0 | 0 | - 500 |
| Issue of additional Tier-1 instruments included in equity | 0 | 0 | 0 | 0 | 0 | 0 | - 6 | 0 | - 6 | 0 | 1 400 | 0 | 1 394 |
| Impact business combinations | 0 | 0 | 0 | 0 | 0 | 0 | - 2 | 0 | - 2 | 0 | 0 | 0 | - 2 |
| Change in minorities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in scope | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - 358 | - 358 |
| Total change | 0 | 0 | 0 | 538 | - 583 | - 110 | 1 102 | 67 | 1 014 | - 333 | 1 400 | - 358 | 1 723 |
| Balance at the end of the period | 1 452 | 5 404 | 0 | 1 632 | - 1 080 | - 45 | 5 750 | - 273 | 12 840 | 2 000 | 1 400 | - 3 | 16 237 |
| of which revaluation reserve for shares of which revaluation reserve for bonds of which revaluation reserve for other assets than bonds and shares |
309 1 322 0 |
||||||||||||
| of which relating to equity method | 20 | 0 | 0 | 1 | 21 |
The changes in equity do not include any dividend or coupon for 2013 as none is paid out. For 2014, KBC foresees a dividend of up to 2 euros per share. On 8 January 2014, KBC repaid 0.33 billion euros (plus a penalty of 50% or 0.17 billion euros) worth of core-capital securities to the Flemish Regional Government.
In 1Q 2014, the placement of an additional tier-1 instrument for an amount of 1.4 billion euros positively contributed to the total equity. The quarterly coupon on this additional tier-1 instrument is presented as dividend (total -28 million euros after tax in 2Q and 3Q 2014 combined).
During 2Q 2014, KBC executed a call on all of its Trust preferred securities which negatively influences the minority interests in equity for an amount of approximately -358 million euros. In 9M 2014, revaluation reserves (AFS assets) increased by 538 million euros mainly due to decreasing interest rates which positively contributed to reserves on bonds to the tune of 551 million euros (of which 151 million euros in 3Q 2014). This was offset by a slightly negative impact on reserves on shares to the tune of -14 million euros. A negative effect, also for a large part linked to decreasing interest rates, of -583 million euros (of which -211 million euros in 3Q 2014) was noted on hedging reserves (cashflow hedges).
| In millions of EUR | 9M 2013 | 9M 2014 |
|---|---|---|
| Net cash from (used in) operating activities | 14 733 | 10 086 |
| Net cash from (used in) investing activities | - 2 849 | 540 |
| Net cash from (used in) financing activities | - 1 534 | - 6 461 |
| Change in cash and cash equivalents | ||
| Net increase or decrease in cash and cash equivalents | 10 350 | 4 166 |
| Cash and cash equivalents at the beginning of the period | 982 | 8 803 |
| Effects of exchange rate changes on opening cash and cash equivalents | - 106 | - 22 |
| Cash and cash equivalents at the end of the period | 11 226 | 12 947 |
On 8 January 2014, KBC repaid 0.33 billion euros principal (plus a penalty of 50% or 0.17 billion euros) to the Flemish Regional Government. This has had an influence in the first quarter of 2014 on the net cash from financing activities to the tune of -0.5 billion euros.
Also in the first quarter of 2014, the issue of an additional tier-1 instrument in March 2014 has had an influence on the net cash from financing activities to the tune of +1.4 billion euros. However, maturing senior unsecured debt and subordinated debt, more than counterbalanced this positive influence.
During the second quarter of 2014 a number of subordinated instruments were called which led to a negative impact of approximately -2.3 billion euros on net cash from financing activities.
The decision not to sell, but to wind down Antwerp Diamond Bank (ADB) (decided on 19 September 2014) has had no significant effect on cash flows at the level of KBC Group and neither did the closure of the sale of KBC Bank Deutschland (closed at 30 September 2014).
The consolidated financial statements of the KBC Group have been prepared in accordance with the International Financial Reporting Standards (IAS 34) as adopted for use in the European Union ('endorsed IFRS'). The interim condensed consolidated financial statements do not include all the information and disclosures required in the annual financial statements, and should be read in conjunction with the Group's annual financial statements as at 31 December 2013.
IFRS 10, 11 and 12 are the new consolidation standards that became effective in the European Union on or after 1 January 2014. IFRS 10 includes a new definition of control, which could, but at KBC did not lead to changes in the scope of consolidation. Under IFRS 11 (Joint Arrangements), it is specified that joint ventures must be accounted for using the equity method and no longer by proportionate consolidation. IFRS 12 combines all the disclosure requirements for subsidiaries, joint arrangements, associates and structured entities (the new name for Special Purpose Entities).The main change for KBC is the application of the equity method instead of proportionate consolidation for Českomoravská Stavební Spořitelna (ČMSS), a jointly owned subsidiary of ČSOB. This change does not affect the result after tax or parent shareholders' equity, but it has an impact on various items in the consolidated income statement and balance sheet. The disclosure requirements will be added to the annual report for 2014.
IFRIC 21 (Levies) was endorsed by the European Union in June 2014 with application date as from 1 January 2015 and with retroactive application. As a result KBC may have to restate its comparable quarterly figures for 2014 (relates solely to movements between quarters and has no impact on the figures for the full year). The main consequence of the application of IFRIC 21 in 2015 will be that certain levies will need to be taken upfront which will negatively impact the first quarter results in 2015.
A summary of the main accounting policies is provided in the Group's annual financial statements as at 31 December 2013.
KBC is structured and managed according to a number of segments (called 'business units'). For reporting purposes, the business units are:
Up until 1 May 2014, the management structure of the group also included an International Product Factories Business Unit. From 1 May 2014 onward, this is merged with the International Markets Business Unit. The results of the activities of the former International Product Factories Business Unit have always been and will continue to be included in the results of the business units based on geography. This merger, therefore will not influence the results of the International Markets Business Unit as compared to the situation before the merger.
Inter-segment transactions are presented at arm's length.
The figures of the segment reporting have been prepared in accordance with the general KBC accounting policies (see note 1) and are thus in compliance with the International Financial Reporting Standards as adopted for use in the European Union (endorsed IFRS).
In addition to the figures according to IFRS, KBC provides figures aimed at giving more insight into the ongoing business performance. The resulting figures are called 'adjusted net result' and are the current basis for the segment reporting.
This means that, over and above the IFRS profit and loss account, a reworked profit and loss account is provided, in which a limited number of non-operational items is excluded from the P/L and summarised into three lines at the bottom of the reporting presentation. Segment reporting is based on this reworked presentation.
These non-operational items are:
In the segment reporting presentation, these items are all assigned to the Group Centre.
In the IFRS accounts, income related to trading activities is split across different components. While trading gains are recognised under 'net result from financial instruments at fair value', the funding costs and commissions paid in order to realise these trading gains are recognised respectively under 'net interest income' and 'net fee and commission income'. Moreover, part of the 'dividend income', 'net realised result on available-for-sale assets' and 'other net income' are also related to trading income. In the net adjusted result of the Belgian Business Unit (KBC Bank Belgium), all trading income components within investment banking are recognised under 'net result from financial instruments at fair value', without any impact on net profit. This recognition is not done for the other business units due to materiality.
| Business Business unit Interna inter Inter unit unit Czech tional of which: of which: of which: of which: segment segment In millions of EUR Belgium Republic Markets Hungary Slovakia Bulgaria Ireland eliminations eliminations Group 9M 2013 Net interest income 1 968 692 478 200 148 30 100 - 143 - 2 2 993 Non-life insurance before reinsurance 323 36 60 21 16 22 0 4 - 14 409 Earned premiums Non-life 714 127 116 45 19 53 0 - 1 - 15 942 Technical charges Non-life - 391 - 91 - 57 - 23 - 3 - 31 0 6 0 - 533 Life insurance before reinsurance - 208 19 2 - 8 7 2 0 4 - 2 - 185 Earned premiums Life 536 137 63 10 42 11 0 15 - 2 750 Technical charges Life - 744 - 118 - 62 - 18 - 35 - 9 0 - 11 0 - 936 Ceded reinsurance result - 5 8 - 5 - 1 - 1 - 3 0 4 0 2 Dividend income 33 0 0 0 0 0 0 0 0 34 Net result from financial instruments at fair value through profit or loss 419 68 73 61 15 1 - 3 60 0 620 Net realised result from available-for-sale assets 155 12 12 7 3 2 1 4 0 183 Net fee and commission income 819 136 136 101 32 1 - 2 11 5 1 108 Net other income 239 13 22 15 9 - 2 0 19 2 296 TOTAL INCOME 3 745 985 776 395 229 54 95 - 36 - 10 5 459 Operating expenses - 1 687 - 463 - 542 - 300 - 134 - 38 - 67 - 161 10 - 2 843 Impairment - 303 - 33 - 362 - 35 - 25 - 16 - 286 - 76 0 - 775 on loans and receivables - 263 - 34 - 350 - 32 - 25 - 7 - 286 - 47 0 - 693 on available-for-sale assets - 5 0 - 10 0 0 - 10 0 - 3 0 - 18 on goodwill 0 0 0 0 0 0 0 - 7 0 - 7 on other - 35 0 - 2 - 2 0 0 0 - 20 0 - 57 Share in results of associated companies and joint ventures 0 23 1 1 0 0 0 0 0 24 RESULT BEFORE TAX 1 754 512 - 126 61 70 0 - 259 - 274 0 1 866 Income tax expense - 561 - 76 4 - 11 - 17 1 32 77 0 - 555 Net post-tax result from discontinued operations 0 0 0 0 0 0 0 0 0 0 RESULT AFTER TAX 1 193 435 - 122 50 53 1 - 227 - 196 0 1 310 Attributable to minority interests 0 0 0 0 0 0 0 11 0 10 ADJUSTED NET RESULT 1 193 435 - 122 50 53 1 - 227 - 207 0 1 300 Legacy CDOs 0 0 0 0 0 0 0 380 0 380 Own credit risk 0 0 0 0 0 0 0 - 34 0 - 34 Divestments 0 0 0 0 0 0 0 - 337 0 - 337 NET RESULT 1 193 435 - 122 50 53 1 - 227 - 198 0 1 309 9M 2014 Net interest income 2 127 649 508 211 157 31 108 - 130 4 3 158 Non-life insurance before reinsurance 297 54 46 20 14 13 0 6 - 14 389 Earned premiums Non-life 721 122 114 41 20 52 0 2 - 14 944 Technical charges Non-life - 423 - 68 - 68 - 22 - 7 - 40 0 4 0 - 555 Life insurance before reinsurance - 196 17 9 - 3 9 3 0 1 - 2 - 171 Earned premiums Life 717 123 65 11 42 12 0 1 - 2 904 Technical charges Life - 913 - 106 - 56 - 14 - 34 - 9 0 0 0 - 1 075 Ceded reinsurance result 3 - 5 3 - 2 - 1 6 0 5 0 6 Dividend income 38 0 0 0 0 0 0 1 0 39 Net result from financial instruments at fair value through profit or loss 1 44 59 54 11 1 - 8 0 0 103 Net realised result from available-for-sale assets 94 8 15 14 1 0 0 10 0 127 Net fee and commission income 857 143 154 119 34 1 - 2 20 - 2 1 171 Net other income 204 12 - 224 - 225 1 1 0 - 7 7 - 8 TOTAL INCOME 3 425 922 570 188 225 56 98 - 94 - 8 4 814 Operating expenses - 1 685 - 437 - 549 - 276 - 139 - 38 - 95 - 126 8 - 2 789 Impairment - 155 - 18 - 212 - 36 - 12 - 7 - 157 - 39 0 - 424 on loans and receivables - 132 - 17 - 211 - 35 - 12 - 7 - 157 - 38 0 - 398 on available-for-sale assets - 13 0 0 0 0 0 0 - 1 0 - 14 on goodwill 0 0 0 0 0 0 0 0 0 0 on other - 11 0 - 1 - 1 0 0 0 0 0 - 12 Share in results of associated companies and joint ventures - 1 18 0 0 0 0 0 2 0 19 RESULT BEFORE TAX 1 584 485 - 191 - 124 74 11 - 154 - 258 0 1 620 Income tax expense - 467 - 77 16 15 - 18 0 20 59 0 - 469 Net post-tax result from discontinued operations 0 0 0 0 0 0 0 0 0 0 RESULT AFTER TAX 1 118 408 - 175 - 109 56 11 - 134 - 199 0 1 152 Attributable to minority interests 0 0 0 0 0 0 0 0 0 0 ADJUSTED NET RESULT 1 117 408 - 175 - 109 56 11 - 134 - 199 0 1 151 Legacy CDOs 0 0 0 0 0 0 0 23 0 23 Own credit risk 0 0 0 0 0 0 0 0 0 0 Divestments 0 0 0 0 0 0 0 131 0 131 |
Business | Group Centre excl |
|||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| KBC | |||||||||||
| NET RESULT | 1 117 | 408 | - 175 | - 109 | 56 | 11 | - 134 | - 45 | 0 | 1 305 |
Legacy CDO's: Over 9M 2014, improvements in market price of corporate credit as reflected in tightened credit default swap spreads generated a value mark-up of KBC's CDO exposure. This was offset by the de-risking of the legacy CDO portfolio during 9M 2014. The most recent de-risking (September 2014) resulted in KBC collapsing the two remaining CDOs in its portfolio. The impact of this latter de-risking was slightly above -20 million euros.
The total result also includes the impact of the government guarantee and the related fee, and the coverage (60%) of the CDOlinked counterparty risk against MBIA, a US monoline insurer. For both of these parties the agreements have been unwound as of the collapse of the last CDO.
Divestments: In 3Q 2014 KBC decided to wind down (instead of sell) Antwerp Diamond Bank. Since it is therefore no longer considered for treatment under IFRS 5 there was an impact to the tune of +123 million euros after tax largely related to the reversal of the impairment recorded in 2012 and 2013 for the sale. Closing the sale for KBC Bank Deutschland (30 September 2014) has had no significant impact.
Own credit risk: In the first nine months of 2014, there was only limited influence on the results.
In the table below, an overview is provided of a number of balance sheet items divided by segment.
| Business | Business | Business unit Interna |
|||||||
|---|---|---|---|---|---|---|---|---|---|
| In millions of EUR | unit Belgium |
unit Czech Republic |
tional Markets |
of which: Hungary |
of which: Slovakia |
of which: Bulgaria |
of which: Ireland |
Group Centre |
KBC Group |
| 31-12-2013 | |||||||||
| Deposits from customers & debt certificates excl. repos | 97 051 | 21 834 | 14 472 | 5 878 | 4 583 | 544 | 3 466 | 17 123 | 150 480 |
| Loans & advances to customers excluding reverse repos | 81 673 | 15 684 | 21 261 | 3 864 | 4 248 | 612 | 12 537 | 1 080 | 119 698 |
| Term loans excl. Reverse repos | 40 566 | 6 279 | 5 612 | 1 772 | 1 488 | 242 | 2 111 | 1 048 | 53 506 |
| Mortgage loans | 31 146 | 6 522 | 13 925 | 1 548 | 1 722 | 236 | 10 419 | 24 | 51 617 |
| Current accounts advances | 1 847 | 19 | 586 | 262 | 324 | 0 | 0 | 0 | 2 451 |
| Finance leases | 3 200 | 359 | 484 | 92 | 385 | 0 | 7 | 0 | 4 044 |
| Consumer credit | 1 251 | 1 538 | 533 | 112 | 287 | 134 | 0 | 0 | 3 322 |
| Other | 3 663 | 967 | 121 | 80 | 41 | 0 | 0 | 8 | 4 758 |
| 30-09-2014 | |||||||||
| Deposits from customers & debt certificates excl. repos | 103 984 | 21 385 | 14 581 | 5 298 | 4 748 | 565 | 3 970 | 11 448 | 151 399 |
| Loans & advances to customers excluding reverse repos | 84 086 | 15 899 | 21 059 | 4 023 | 4 464 | 664 | 11 908 | 2 157 | 123 202 |
| Term loans excl. Reverse repos | 41 380 | 5 975 | 5 364 | 1 966 | 1 441 | 277 | 1 680 | 1 967 | 54 686 |
| Mortgage loans | 31 518 | 7 142 | 13 715 | 1 511 | 1 740 | 243 | 10 221 | 26 | 52 400 |
| Current accounts advances | 2 758 | 1 082 | 688 | 309 | 378 | 0 | 1 | 150 | 4 678 |
| Finance leases | 3 147 | 416 | 506 | 91 | 408 | 0 | 6 | 0 | 4 069 |
| Consumer credit | 1 126 | 1 010 | 685 | 82 | 460 | 144 | 0 | 0 | 2 822 |
| Other | 4 157 | 274 | 101 | 64 | 37 | 0 | 0 | 15 | 4 547 |
| In millions of EUR | 3Q 2013 | 2Q 2014 | 3Q 2014 | 9M 2013 | 9M 2014 |
|---|---|---|---|---|---|
| Total | 1 014 | 1 056 | 1 120 | 3 069 | 3 185 |
| Interest income | 2 037 | 1 971 | 2 010 | 6 276 | 5 911 |
| Available-for-sale assets | 197 | 185 | 183 | 637 | 563 |
| Loans and receivables | 1 207 | 1 143 | 1 171 | 3 723 | 3 381 |
| Held-to-maturity investments | 266 | 262 | 271 | 780 | 765 |
| Other assets not at fair value | 5 | 1 | 8 | 12 | 13 |
| Subtotal, interest income from financial assets not measured at fair value through | |||||
| profit or loss | 1 675 | 1 592 | 1 633 | 5 152 | 4 722 |
| Financial assets held for trading | 196 | 198 | 260 | 688 | 683 |
| Hedging derivatives | 127 | 132 | 77 | 343 | 348 |
| Other financial assets at fair value through profit or loss | 39 | 49 | 40 | 92 | 158 |
| Interest expense | -1 023 | - 915 | - 890 | -3 207 | -2 726 |
| Financial liabilities measured at amortised cost | - 551 | - 462 | - 438 | -1 745 | -1 331 |
| Other | - 1 | - 1 | - 1 | - 4 | - 3 |
| Subtotal, interest expense for financial liabilities not measured at fair value | |||||
| through profit or loss | - 552 | - 463 | - 439 | -1 749 | -1 334 |
| Financial liabilities held for trading | - 236 | - 259 | - 265 | - 812 | - 795 |
| Hedging derivatives | - 187 | - 151 | - 161 | - 524 | - 491 |
| Other financial liabilities at fair value through profit or loss | - 45 | - 40 | - 24 | - 114 | - 101 |
| Net interest expense on defined benefit plans | - 2 | - 1 | - 1 | - 7 | - 5 |
In 9M 2014, the result from financial instruments at fair value through profit or loss was influenced by:
| In millions of EUR | 3Q 2013 | 2Q 2014 | 3Q 2014 | 9M 2013 | 9M 2014 |
|---|---|---|---|---|---|
| Total | 34 | 49 | 28 | 223 | 128 |
| Breakdown by portfolio | |||||
| Fixed-income securities | 28 | 23 | 17 | 116 | 56 |
| Shares | 6 | 26 | 11 | 107 | 72 |
In 9M 2014, the net realised result from available-for-sale assets is for the largest part related to sales of shares at KBC Insurance.
| In millions of EUR | 3Q 2013 | 2Q 2014 | 3Q 2014 | 9M 2013 | 9M 2014 |
|---|---|---|---|---|---|
| Total | 337 | 387 | 402 | 1 107 | 1 163 |
| Fee and commission income | 507 | 533 | 579 | 1 704 | 1 668 |
| Securities and asset management | 246 | 290 | 302 | 803 | 870 |
| Margin on deposit accounting (life insurance investment contracts w ithout DPF) |
12 | 22 | 26 | 90 | 68 |
| Commitment credit | 61 | 60 | 61 | 187 | 180 |
| Payments | 137 | 127 | 133 | 396 | 390 |
| Other | 51 | 34 | 57 | 227 | 161 |
| Fee and commission expense | - 170 | - 147 | - 177 | - 596 | - 505 |
| Commission paid to intermediaries | - 73 | - 71 | - 75 | - 224 | - 219 |
| Other | - 97 | - 76 | - 101 | - 373 | - 286 |
| In millions of EUR | 3Q 2013 | 2Q 2014 | 3Q 2014 | 9M 2013 | 9M 2014 |
|---|---|---|---|---|---|
| Total | 51 | - 99 | 73 | 107 | 26 |
| Of which net realised result following | |||||
| The sale of loans and receivables | - 97 | 2 | 1 | - 100 | 3 |
| The sale of held-to-maturity investments | 0 | 0 | 0 | 0 | 0 |
| The repurchase of financial liabilities measured at amortised cost | 0 | 0 | 0 | - 1 | 0 |
| Other: of which: | 148 | - 101 | 72 | 208 | 23 |
| Income concerning leasing at the KBC Lease-group | 25 | 16 | 21 | 69 | 61 |
| Income from Group VAB | 15 | 16 | 16 | 50 | 51 |
| Realised gains or losses on divestments | 0 | 16 | 10 | - 94 | 24 |
| Legal interests | 66 | 0 | 0 | 66 | 0 |
| New law on retail loans (Hungary) | 0 | - 231 | 0 | 0 | - 231 |
| Legal settlement in 2Q14 of an old credit file | 0 | 31 | 0 | 0 | 31 |
In 2Q 2014, there was an impact to the tune of -231 million euros pre-tax (-183 million euros after tax) due to the on 4 July by the Hungarian parliament adopted act 'Resolution of certain issues related to the Supreme Court's (Curia) uniformity decision on consumer loan agreements concluded by financial institutions' and the guidelines issued by the Hungarian Central Bank at the end of July. For more information, see KBC's press release from 8 July 2014 on www.kbc.com.
| Non-technical | ||||
|---|---|---|---|---|
| In millions of EUR | Life | Non-life | account | TOTAL |
| 9M 2013 | ||||
| Earned premiums, insurance (before reinsurance) | 752 | 956 | - | 1 708 |
| Technical charges, insurance (before reinsurance) | - 935 | - 533 | - | - 1 468 |
| Net fee and commission income | 17 | - 171 | - | - 154 |
| Ceded reinsurance result | - 1 | 3 | 0 | 2 |
| Operating expenses | - 93 | - 181 | - 2 | - 276 |
| Internal costs claim paid | - 5 | - 45 | - | - 50 |
| Administration costs related to acquisitions | - 25 | - 53 | - | - 78 |
| Administration costs | - 63 | - 83 | - | - 146 |
| Management costs investments | 0 | 0 | - 2 | - 2 |
| Technical result | - 260 | 74 | - 2 | - 188 |
| Net interest income | 530 | 530 | ||
| Dividend income | 24 | 24 | ||
| Net result from financial instruments at fair value | 275 | 275 | ||
| Net realised result from AFS assets | 41 | 41 | ||
| Net other income | - 42 | - 42 | ||
| Impairments | - 79 | - 79 | ||
| Allocation to the technical accounts | 479 | 82 | - 561 | 0 |
| Technical-financial result | 219 | 155 | 187 | 561 |
| Share in results of associated companies and joint ventures | 0 | 0 | ||
| RESULT BEFORE TAX | 219 | 155 | 187 | 561 |
| Income tax expense | - 193 | |||
| Net post-tax result from discontinued operations | 0 | |||
| RESULT AFTER TAX | 368 | |||
| attributable to minority interest | 0 | |||
| attributable to equity holders of the parent | 368 | |||
| 9M 2014 | ||||
| Earned premiums, insurance (before reinsurance) | 906 | 958 | - | 1 865 |
| Technical charges, insurance (before reinsurance) | - 1 075 | - 555 | - | - 1 630 |
| Net fee and commission income | - 7 | - 174 | 0 | - 181 |
| Ceded reinsurance result | - 1 | 8 | 0 | 6 |
| Operating expenses | - 88 | - 179 | - 1 | - 268 |
| Internal costs claim paid | - 6 | - 43 | - | - 49 |
| Administration costs related to acquisitions | - 21 | - 56 | - | - 77 |
| Administration costs | - 62 | - 80 | - | - 141 |
| Management costs investments | 0 | 0 | - 1 | - 1 |
| Technical result | - 265 | 58 | - 1 | - 208 |
| Net interest income | 507 | 507 | ||
| Dividend income | 34 | 34 | ||
| Net result from financial instruments at fair value | 42 | 42 | ||
| Net realised result from AFS assets | 81 | 81 | ||
| Net other income | 1 | 1 | ||
| Impairments | - 15 | - 15 | ||
| Allocation to the technical accounts | 486 | 81 | - 566 | 0 |
| Technical-financial result | 220 | 139 | 83 | 443 |
| Share in results of associated companies and joint ventures | 2 | 2 | ||
| RESULT BEFORE TAX | 220 | 139 | 85 | 445 |
| Income tax expense | - 124 | |||
| Net post-tax result from discontinued operations | ||||
| RESULT AFTER TAX | 321 | |||
| attributable to minority interest | 0 | |||
| attributable to equity holders of the parent | 320 |
Note: Figures for premium income exclude the investment contracts without DPF, which roughly coincide with the unit-linked products. Figures are before elimination of transactions between the bank and insurance entities of the group (more information in the 2013 annual report).
Due to a presentation change in 9M 2013 figures, 55 million euros in net fee and commission income was transferred from the non-technical account to Life.
The results of 2Q 2014 were negatively influenced for an amount of -41 million euros after reinsurance (pre-tax) by severe hailstorms in Belgium in June 2014. Any additional claims had no further impact as these are covered by reinsurance.
| In millions of EUR | 3Q 2013 | 2Q 2014 | 3Q 2014 | 9M 2013 | 9M 2014 |
|---|---|---|---|---|---|
| Total | - 362 | - 142 | - 58 | - 987 | - 313 |
| Impairment on loans and receivables | - 230 | - 136 | - 190 | - 777 | - 429 |
| Breakdown by type | |||||
| Specific impairments for on-balance-sheet lending | - 216 | - 189 | - 190 | - 712 | - 528 |
| Provisions for off-balance-sheet credit commitments | 15 | 20 | 5 | 7 | 23 |
| Portfolio-based impairments | - 28 | 33 | - 5 | - 72 | 77 |
| Breakdown by business unit | |||||
| Business unit Belgium | - 43 | - 34 | - 64 | - 263 | - 132 |
| Business unit Czech Republic | - 6 | - 2 | - 14 | - 34 | - 17 |
| Business unit International Markets | - 118 | - 84 | - 63 | - 350 | - 211 |
| of which: Hungary | - 12 | - 13 | - 11 | - 32 | - 35 |
| of which: Slovakia | - 7 | - 6 | - 3 | - 25 | - 12 |
| of which: Bulgaria | - 1 | - 3 | - 2 | - 7 | - 7 |
| of which: Ireland | - 98 | - 62 | - 47 | - 286 | - 157 |
| Group Centre | - 62 | - 17 | - 49 | - 130 | - 69 |
| Impairment on available-for-sale assets | - 8 | - 3 | - 6 | - 24 | - 14 |
| Breakdown by type | |||||
| Shares | - 8 | - 3 | - 6 | - 14 | - 14 |
| Other | 0 | 0 | 0 | - 10 | 0 |
| Impairment on goodwill | 0 | 0 | 0 | - 7 | 0 |
| Impairment on other | - 125 | - 3 | 139 | - 179 | 130 |
| Intangible assets, other than goodwill | 0 | 0 | 0 | 0 | 0 |
| Property and equipment and investment property | - 31 | 0 | 0 | - 46 | - 1 |
| Held-to-maturity assets | 0 | 0 | 0 | 0 | 1 |
| Associated companies and joint ventures | 0 | 0 | 0 | 0 | 0 |
| Other | - 93 | - 2 | 139 | - 133 | 130 |
In 3Q 2014 KBC decided to wind down (instead of sell) Antwerp Diamond Bank. Since it is therefore no longer considered for treatment under IFRS 5 there was an impact on other – other which includes the reversal of the impairment recorded in 2012 and 2013 for the sale.
| Held for | Designated at | Available for | Loans and | Held to | Hedging | Measured at | |||
|---|---|---|---|---|---|---|---|---|---|
| (In millions of EUR) | trading | fair value | sale | receivables | maturity | derivatives | amortised cost | Total Pro forma | |
| FINANCIAL ASSETS, 31-12-2013 | |||||||||
| Loans and advances to credit institutions and investment firms a | 5 100 | 1 596 | 0 | 9 571 | - | - | - | 16 267 | 16 294 |
| Loans and advances to customers b | 706 | 774 | 0 | 118 892 | - | - | - | 120 371 | 121 534 |
| Excluding reverse repos | 703 | 200 | 0 | 118 796 | - | - | - | 119 698 | 120 861 |
| Discount and acceptance credit | 0 | 0 | 0 | 605 | - | - | - | 605 | 605 |
| Consumer credit | 0 | 0 | 0 | 3 322 | - | - | - | 3 322 | 3 322 |
| Mortgage loans | 0 | 34 | 0 | 51 583 | - | - | - | 51 617 | 51 617 |
| Term loans | 696 | 697 | 0 | 52 786 | - | - | - | 54 179 | 55 125 |
| Finance leasing | 0 | 0 | 0 | 4 044 | - | - | - | 4 044 | 4 044 |
| Current account advances | 0 | 0 | 0 | 2 451 | - | - | - | 2 451 | 2 667 |
| Securitised loans | 0 | 0 | 0 | 0 | - | - | - | 0 | 0 |
| Other | 10 | 43 | 0 | 4 101 | - | - | - | 4 154 | 4 154 |
| Equity instruments | 283 | 8 | 1 579 | - | - | - | - | 1 870 | 1 868 |
| Investment contracts (insurance) | - | 12 745 | - | - | - | - | - | 12 745 | 12 745 |
| Debt securities issued by | 2 974 | 1 319 | 25 728 | 1 690 | 31 323 | - | - | 63 034 | 62 168 |
| Public bodies | 2 385 | 771 | 17 337 | 118 | 29 630 | - | - | 50 240 | 49 409 |
| Credit institutions and investment firms | 268 | 195 | 3 289 | 154 | 1 040 | - | - | 4 946 | 4 911 |
| Corporates | 321 | 353 | 5 102 | 1 418 | 654 | - | - | 7 848 | 7 848 |
| Derivatives | 7 823 | - | - | - | - | 777 | - | 8 600 | 8 603 |
| Total carrying value | 16 885 | 16 441 | 27 307 | 130 153 | 31 323 | 777 | 0 | 222 887 | 223 212 |
| a Of which reverse repos |
8 483 | 8 483 | |||||||
| b Of which reverse repos | 673 | 673 | |||||||
| FINANCIAL ASSETS, 30-09-2014 | |||||||||
| Loans and advances to credit institutions and investment firms a | 254 | 1 165 | 0 | 15 662 | - | - | - | 17 080 | |
| Loans and advances to customers b | 106 | 2 575 | 0 | 123 217 | - | - | - | 125 898 | |
| Excluding reverse repos | 20 | 124 | 0 | 123 057 | - | - | - | 123 202 | |
| Trade receivables | 0 | 0 | 0 | 3 030 | - | - | - | 3 030 | |
| Consumer credit | 0 | 0 | 0 | 2 822 | - | - | - | 2 822 | |
| Mortgage loans | 0 | 33 | 0 | 52 367 | - | - | - | 52 400 | |
| Term loans | 86 | 2 542 | 0 | 54 755 | - | - | - | 57 383 | |
| Finance leasing | 0 | 0 | 0 | 4 069 | - | - | - | 4 069 | |
| Current account advances | 0 | 0 | 0 | 4 678 | - | - | - | 4 678 | |
| Securitised loans | 0 | 0 | 0 | 0 | - | - | - | 0 | |
| Other | 20 | 0 | 0 | 1 497 | - | - | - | 1 517 | |
| Equity instruments | 297 | 4 | 1 669 | - | - | - | - | 1 970 | |
| Investment contracts (insurance) | - | 13 425 | - | - | - | - | - | 13 425 | |
| Debt securities issued by | 4 283 | 1 681 | 29 289 | 1 239 | 31 067 | - | - | 67 560 | |
| Public bodies | 3 878 | 930 | 18 558 | 37 | 29 598 | - | - | 53 001 | |
| Credit institutions and investment firms | 235 | 346 | 4 437 | 157 | 866 | - | - | 6 041 | |
| Corporates | 170 | 405 | 6 295 | 1 045 | 603 | - | - | 8 518 | |
| Derivatives | 8 092 | - | - | - | - | 1 062 | - | 9 153 | |
| Total carrying value | 13 032 | 18 850 | 30 958 | 140 118 | 31 067 | 1 062 | 0 | 235 087 | |
| a Of which reverse repos |
8 953 | ||||||||
| b Of which reverse repos | 2 697 |
As of 2Q 2014, in order to provide a more transparent product view, factoring is no longer included in the other loans and advances to customers (total impacted amount of 2.4 billion euros), but – together with the discount and acceptance credits – combined in trade receivables.
Pro forma: the figures of 31-12-2013 are presented pro forma for comparability reasons, whereby the figures of Antwerp Diamond Bank are added (shift from non-current assets held for sale and disposal groups) and the figures of Transformation fund (subsidiary of ČSOB (Czech Republic)) are deducted since it has been deconsolidated as from 3Q 2014.
| Held for trading |
Designated at fair value |
Available for sale |
Loans and receivables |
Held to maturity |
Hedging derivatives |
Measured at amortised cost |
|||
|---|---|---|---|---|---|---|---|---|---|
| (In millions of EUR) | Total Pro forma | ||||||||
| FINANCIAL LIABILITIES, 31-12-2013 | |||||||||
| Deposits from credit institutions and investment firms a | 939 | 896 | - | - | - | - | 12 884 | 14 719 | 14 733 |
| Deposits from customers and debt certificates b | 3 634 | 12 248 | - | - | - | - | 145 253 | 161 135 160 182 | |
| Excluding repos | 319 | 5 292 | - | - | - | - | 144 869 | 150 480 149 527 | |
| Deposits from customers | 3 348 | 7 836 | - | - | - | - | 120 538 | 131 722 130 769 | |
| Demand deposits | 0 | 50 | - | - | - | - | 38 999 | 39 049 | 39 277 |
| Time deposits | 3 347 | 7 786 | - | - | - | - | 43 837 | 54 970 | 54 973 |
| Savings deposits | 0 | 0 | - | - | - | - | 34 990 | 34 990 | 34 990 |
| Special deposits | 0 | 0 | - | - | - | - | 1 335 | 1 335 | 1 335 |
| Other deposits | 0 | 0 | - | - | - | - | 1 378 | 1 378 | 195 |
| Debt certificates | 286 | 4 412 | - | - | - | - | 24 715 | 29 413 | 29 413 |
| Certificates of deposit | 0 | 6 | - | - | - | - | 3 540 | 3 546 | 3 546 |
| Customer savings certificates Convertible bonds |
0 0 |
0 0 |
- - |
- - |
- - |
- - |
473 0 |
473 0 |
473 0 |
| Non-convertible bonds | 286 | 3 763 | - | - | - | - | 14 869 | 18 919 | 18 919 |
| Convertible subordinated liabilities | 0 | 0 | - | - | - | - | 0 | 0 | 0 |
| Non-convertible subordinated liabilities | 0 | 643 | - | - | - | - | 5 832 | 6 475 | 6 475 |
| Liabilities under investment contracts | - | 11 787 | - | - | - | - | 0 | 11 787 | 11 787 |
| Derivatives | 8 161 | - | - | - | - | 1 678 | - | 9 838 | 9 844 |
| Short positions | 386 | 0 | - | - | - | - | - | 386 | 386 |
| in equity instruments | 40 | 0 | - | - | - | - | - | 40 | 40 |
| in debt instruments | 345 | 0 | - | - | - | - | - | 345 | 345 |
| Other | 0 | 0 | - | - | - | - | 1 556 | 1 556 | 1 556 |
| Total carrying value | 13 119 | 24 931 | - | - | - | 1 678 | 159 693 | 199 421 198 488 | |
| a Of which repos | 1 672 | 1 672 | |||||||
| b Of which repos |
10 655 | 10 655 | |||||||
| FINANCIAL LIABILITIES, 30-09-2014 | |||||||||
| Deposits from credit institutions and investment firms a | 361 | 2 697 | - | - | - | - | 15 342 | 18 399 | |
| Deposits from customers and debt certificates b | 683 | 13 262 | - | - | - | - | 152 898 | 166 843 | |
| Excluding repos | 319 | 3 224 | - | - | - | - | 147 856 | 151 399 | |
| Deposits from customers | 408 | 10 855 | - | - | - | - | 130 621 | 141 883 | |
| Demand deposits | 0 | 0 | - | - | - | - | 46 059 | 46 059 | |
| Time deposits | 408 | 10 834 | - | - | - | - | 45 417 | 56 658 | |
| Savings deposits | 0 | 0 | - | - | - | - | 37 005 | 37 005 | |
| Special deposits | 0 | 0 | - | - | - | - | 1 766 | 1 766 | |
| Other deposits | 0 | 21 | - | - | - | - | 374 | 395 | |
| Debt certificates | 275 | 2 407 | - | - | - | - | 22 277 | 24 960 | |
| Certificates of deposit | 0 | 2 | - | - | - | - | 5 520 | 5 522 | |
| Customer savings certificates | 0 | 0 | - | - | - | - | 762 | 762 | |
| Convertible bonds | 0 | 0 | - | - | - | - | 0 | 0 | |
| Non-convertible bonds | 275 | 1 877 | - | - | - | - | 12 770 | 14 922 | |
| Convertible subordinated liabilities | 0 | 0 | - | - | - | - | 0 | 0 | |
| Non-convertible subordinated liabilities | 0 | 528 | - | - | - | - | 3 225 | 3 754 | |
| Liabilities under investment contracts | - | 12 540 | - | - | - | - | 0 | 12 540 | |
| Derivatives | 7 899 | 0 | - | - | - | 2 852 | - | 10 751 | |
| Short positions | 484 | 0 | - | - | - | - | - | 484 | |
| in equity instruments | 55 | 0 | - | - | - | - | - | 55 | |
| in debt instruments | 429 | 0 | - | - | - | - | - | 429 | |
| Other | 0 | 0 | - | - | - | - | 2 995 | 2 995 | |
| Total carrying value | 9 428 | 28 499 | - | - | - | 2 852 | 171 234 | 212 012 | |
| a Of which repos | 3 218 | ||||||||
| b Of which repos |
15 444 |
Pro forma: the figures of 31-12-2013 are presented pro forma for comparability reasons, whereby the figures of Antwerp Diamond Bank are added (shift from liabilities related to disposal groups) and the figures of Transformation fund (subsidiary of ČSOB (Czech Republic)) are deducted since it has been deconsolidated as from 3Q 2014.
| In millions of EUR | 30-09-2013 | 31-12-2013 | 31-03-2014 | 30-06-2014 | 30-09-2014 |
|---|---|---|---|---|---|
| Total customer loans excluding reverse repo | |||||
| Business unit Belgium | 82 472 | 81 673 | 81 967 | 83 542 | 84 086 |
| Business unit Czech Republic | 16 026 | 15 684 | 15 424 | 15 586 | 15 899 |
| Business unit International Markets | 22 471 | 21 261 | 21 119 | 21 038 | 21 059 |
| of which: Hungary | 4 103 | 3 864 | 3 863 | 3 916 | 4 023 |
| of which: Slovakia | 4 247 | 4 248 | 4 342 | 4 436 | 4 464 |
| of which: Bulgaria | 566 | 612 | 603 | 623 | 664 |
| of which: Ireland | 13 556 | 12 537 | 12 311 | 12 064 | 11 908 |
| Group Centre | 1 261 | 1 080 | 1 095 | 1 096 | 2 157 |
| KBC Group | 122 231 | 119 698 | 119 606 | 121 262 | 123 202 |
| Mortgage loans | |||||
| Business unit Belgium | 31 042 | 31 146 | 31 183 | 31 347 | 31 518 |
| Business unit Czech Republic | 6 805 | 6 522 | 6 633 | 6 747 | 7 142 |
| Business unit International Markets | 14 591 | 13 925 | 13 833 | 13 844 | 13 715 |
| of which: Hungary | 1 598 | 1 548 | 1 520 | 1 511 | 1 511 |
| of which: Slovakia | 1 668 | 1 722 | 1 780 | 1 862 | 1 740 |
| of which: Bulgaria | 239 | 236 | 234 | 235 | 243 |
| of which: Ireland | 11 086 | 10 419 | 10 299 | 10 236 | 10 221 |
| Group Centre | 26 | 24 | 24 | 24 | 26 |
| KBC Group | 52 465 | 51 617 | 51 674 | 51 963 | 52 400 |
| Customer deposits and debt certificates excl. repos | |||||
| Business unit Belgium | 100 071 | 97 051 | 100 471 | 100 910 | 103 984 |
| Business unit Czech Republic | 22 330 | 21 834 | 22 025 | 22 390 | 21 385 |
| Business unit International Markets | 14 730 | 14 472 | 14 390 | 14 248 | 14 581 |
| of which: Hungary | 6 214 | 5 878 | 5 442 | 5 175 | 5 298 |
| of which: Slovakia | 4 508 | 4 583 | 4 555 | 4 547 | 4 748 |
| of which: Bulgaria | 534 | 544 | 547 | 553 | 565 |
| of which: Ireland | 3 474 | 3 466 | 3 846 | 3 973 | 3 970 |
| Group Centre | 17 578 | 17 123 | 14 152 | 13 231 | 11 448 |
| KBC Group | 154 709 | 150 480 | 151 039 | 150 778 | 151 399 |
| Technical provisions, Life Insurance In millions of EUR |
30-09-2013 | 31-12-2013 | 31-03-2014 | 30-06-2014 | 30-09-2014 | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Interest | Interest | Interest | Interest | Interest | ||||||
| Guaranteed Unit Linked | Guaranteed Unit Linked | Guaranteed Unit Linked | Guaranteed Unit Linked | Guaranteed Unit Linked | ||||||
| Business unit Belgium | 13 493 | 11 754 | 13 493 | 11 864 | 13 589 | 12 052 | 13 630 | 12 402 | 13 724 | 12 623 |
| Business unit Czech Republic | 570 | 578 | 530 | 546 | 527 | 526 | 520 | 507 | 517 | 502 |
| Business unit International Markets | 228 | 266 | 228 | 272 | 221 | 271 | 219 | 292 | 218 | 300 |
| of which: Hungary | 5 4 |
189 | 5 4 |
193 | 5 3 |
186 | 5 3 |
199 | 5 3 |
203 |
| of which: Slovakia | 139 | 7 4 |
139 | 7 8 |
133 | 8 4 |
129 | 9 2 |
129 | 9 6 |
| of which: Bulgaria | 3 5 |
2 | 3 5 |
1 | 3 6 |
1 | 3 6 |
1 | 3 6 |
1 |
| Group Centre | 5 2 |
6 2 |
5 4 |
6 5 |
0 | 0 | 0 | 0 | 0 | 0 |
| KBC Group | 14 342 | 12 660 | 14 304 | 12 747 | 14 338 | 12 848 | 14 369 | 13 201 | 14 460 | 13 425 |
For more details on how KBC defines and determines (i) fair value and the fair value hierarchy and (ii) level 3 valuations reference is made to notes 23 up to and including 26 of the annual accounts 2013.
| Fair value hierarchy | 31-12-2013 | 30-09-2014 | |||||||
|---|---|---|---|---|---|---|---|---|---|
| In millions of EUR | Level 1 | Level 2 | Level 3 | Total | Level 1 | Level 2 | Level 3 | Total | |
| Financial assets measured at fair value | |||||||||
| Held for trading | 2 556 | 11 846 | 2 483 | 16 885 | 3 703 | 7 216 | 2 113 | 13 032 | |
| Designated at fair value | 13 444 | 2 615 | 382 | 16 441 | 14 460 | 4 035 | 356 | 18 850 | |
| Available for sale | 21 444 | 4 091 | 1 772 | 27 307 | 26 855 | 2 485 | 1 618 | 30 958 | |
| Hedging derivatives | 0 | 777 | 0 | 777 | 0 | 1 062 | 0 | 1 062 | |
| Total | 37 444 | 19 330 | 4 637 | 61 411 | 45 017 | 14 798 | 4 087 | 63 902 | |
| Financial liabilities measured at fair value | |||||||||
| Held for trading | 374 | 10 088 | 2 658 | 13 119 | 485 | 6 756 | 2 186 | 9 428 | |
| Designated at fair value | 11 787 | 12 600 | 543 | 24 931 | 12 539 | 15 610 | 349 | 28 499 | |
| Hedging derivatives | 0 | 1 678 | 0 | 1 678 | 0 | 2 852 | 0 | 2 852 | |
| Total | 12 161 | 24 365 | 3 201 | 39 728 | 13 025 | 25 218 | 2 535 | 40 778 |
In course of the first nine months of 2014, KBC de-risked its legacy CDO portfolio. This de-risking resulted in a decrease of the P/L sensitivity to a +50% credit spread widening from -92 million euros as at 31 December 2013 to an insignificant amount as at 30 September 2014. The remaining minor sensitivity is due to the fact that KBC is still the counterparty to and issuer of a further 0.3 billion euros worth of notes held by investors that will remain outstanding until November 2017. These notes may change in value primarily due to credit spread movements on the underlying portfolio.
In the first nine months of 2014, an approximate total amount of 0.1 billion euros in financial instruments at fair value was transferred from level 1 to level 2. KBC also transferred around 1.4 billion euros in financial instruments at fair value from level 2 to level 1.
| Movements table of assets and liabilities valued in level 3 of the fair value hierarchy – situation at 30-09-2014, in millions of EUR LEVEL 3 FINANCIAL ASSETS |
||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Held for trading | Designated at fair value | Available for sale | Hedging derivatives |
|||||||||
| Loans and advances |
Equity instruments |
Investment contracts |
Debt | securities Derivatives | Loans and advances |
Equity instruments |
Investment contracts |
Debt securities |
Equity instruments |
Debt | securities Derivatives | |
| Opening balance | 0 | 1 | 0 | 342 | 2 141 | 24 | 5 | 0 | 352 | 300 | 1 472 | 0 |
| Total gains/losses | 0 | 0 | 0 | 10 | - 56 | 1 | 1 | 0 | 22 | 10 | - 13 | 0 |
| in profit and loss* | 0 | 0 | 0 | 10 | - 56 | 1 | 1 | 0 | 22 | 1 | - 25 | 0 |
| in other comprehensive income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 9 | 11 | 0 |
| Acquisitions | 0 | 0 | 0 | 3 | 122 | 0 | 0 | 0 | 22 | 1 | 977 | 0 |
| Sales | 0 | 0 | 0 | - 27 | - 89 | 0 | - 5 | 0 | - 2 | - 5 | - 68 | 0 |
| Settlements | 0 | 0 | 0 | - 57 | - 266 | - 2 | 0 | 0 | - 16 | - 1 | - 461 | 0 |
| Transfers into level 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 22 | 0 |
| Transfers out of level 3 | 0 | 0 | 0 | - 31 | 0 | 0 | 0 | 0 | - 28 | 0 | - 657 | 0 |
| Tranfers from/to non-current assets held for sale | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Translation differences | 0 | 0 | 0 | 13 | 8 | 2 | 0 | 0 | 26 | 0 | 2 | 0 |
| Changes in scope | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - 23 | - 3 | - 20 | 0 |
| Other | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - 25 | 62 | 0 | 0 |
| Closing balance | 0 | 1 | 0 | 252 | 1 860 | 26 | 1 | 0 | 329 | 365 | 1 254 | 0 |
| Total gains/losses for the period included in profit and loss for assets held at the end of the period |
0 | 0 | 0 | 16 | 56 | 1 | 1 | 0 | 22 | 0 | 0 | 0 |
| LEVEL 3 FINANCIAL LIABILITIES |
| Held for trading | Designated at fair value | Hedging derivatives | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Deposits from credit institutions |
Deposits from customers and debt certificates |
Liabilities under investment |
contracts Derivatives | Short positions |
Other | Deposits from credit institutions |
Deposits from customers and debt certificates |
Liabilities under investment contracts |
Other | ||
| Opening balance | 0 | 102 | 0 | 2 542 | 13 | 0 | 0 | 543 | 0 | 0 | 0 |
| Total gains/losses | 0 | 3 | 0 | - 159 | 0 | 0 | 0 | - 11 | 0 | 0 | 0 |
| in profit and loss* | 0 | 3 | 0 | - 159 | 0 | 0 | 0 | - 11 | 0 | 0 | 0 |
| in other comprehensive income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Issues | 0 | 0 | 0 | 151 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Repurchases | 0 | - 1 | 0 | 0 | 0 | 0 | 0 | - 200 | 0 | 0 | 0 |
| Settlements | 0 | - 59 | 0 | - 405 | - 13 | 0 | 0 | 0 | 0 | 0 | 0 |
| Transfers into level 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Transfers out of level 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tranfers from/to financial liabilities regarding disposal groups | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Translation differences | 0 | 5 | 0 | 5 | 0 | 0 | 0 | 16 | 0 | 0 | 0 |
| Changes in scope | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Closing balance | 0 | 51 | 0 | 2 135 | 0 | 0 | 0 | 349 | 0 | 0 | 0 |
| Total gains/losses for the period included in profit and loss for liabilities held at the end of the period |
0 | 0 | 0 | - 22 | 0 | 0 | 0 | - 11 | 0 | 0 | 0 |
* Recognised primarily in 'Net result from financial instruments at fair value through profit or loss', 'Net realised result from available-for-sale assets' and 'Impairment on available-for-sale assets'.
| in number of shares | 31-12-2013 | 30-09-2014 |
|---|---|---|
| Ordinary shares | 417 364 358 | 417 364 358 |
| of which ordinary shares that entitle the holder to a dividend payment | 417 364 358 | 417 364 358 |
| of which treasury shares | 802 | 542 |
| Non-voting core-capital securities | 79 096 044 | 67 796 608 |
| Other information | ||
| Par value per ordinary share (in EUR) | 3.48 | 3.48 |
| Number of shares issued but not fully paid up | 0 | 0 |
The ordinary shares of KBC Group NV have no nominal value and are quoted only on NYSE Euronext (Brussels). As mentioned in a press release on 23 October 2014 KBC decided to delist the shares of KBC Group NV from the Luxembourg Stock Exchange. Shareholders could trade their shares on the Luxembourg Stock Exchange until 26 September 2014.
Non-voting core-capital securities: since the end of 2008, KBC Group NV has issued 7 billion euros in perpetual, nontransferable, non-voting core-capital securities that have equal ranking (pari passu) with ordinary shares upon liquidation. These have been subscribed by the Belgian State (the Federal Holding and Investment Company) and Flemish Region (each in the amount of 3.5 billion euros). The other features of the transactions are dealt with under 'Capital transactions and guarantee agreements with the government in 2008 and 2009' in the 'Additional information' section of the annual report 2013.
In 2012, KBC repaid all of the securities held by the Belgian State to the tune of 3.5 billion euros including a 15% penalty (525 million euros in total).
On 3 July 2013, KBC repaid 1.17 billion euros worth of non-voting core capital securities held by the Flemish Regional Government including a 50% penalty (583 million euros in total). On 8 January 2014, KBC repaid 0.33 billion euros (plus a penalty of 50% or 0.17 billion euros) worth of core-capital securities to the Flemish Regional Government.
On 13 March 2014, KBC placed CRD IV-compliant additional tier-1 securities for a total consideration of 1.4 billion euros. These securities qualify as additional tier-1 capital under the Basel III standards (as transposed in CRD IV) and therefore positively influence KBC's tier-1 capital. The securities are perpetual with an optional call from year 5 onwards. Following the instruments' classification as equity, the coupon of 5.625% per annum, payable each quarter is accounted for as dividend. This transaction has no impact on the number of shares.
During the second quarter of 2014, KBC called all its Trust preferred securities for a total amount of 0.4 billion euros. On top of this, KBC also called two other classic subordinated Tier-1 securities, both from KBC Bank NV and for a total consideration of 1.95 billion euros (included in non-convertible subordinated liabilities – see note 18).
On 8 January 2014, KBC repaid 0.33 billion euros (plus a penalty of 50% or 0.17 billion euros) worth of core-capital securities to the Flemish Regional Government.
Over 2013 results, KBC does not pay a coupon on the remaining non-voting core capital securities, given that no dividend is paid on ordinary shares. For 2014, KBC intends to pay a dividend on ordinary shares and therefore also intends to pay a coupon (payment in 2015) on the remaining non-voting core capital securities.
| Company | Consolidation Ownership percentage |
Comments | ||
|---|---|---|---|---|
| method | at group level | |||
| For income statement comparison | 3Q 2013 | 3Q 2014 | ||
| Additions | ||||
| None | ||||
| Exclusions | ||||
| Absolut Bank | Full | ------ | ------ | Sold in 2Q 2013 |
| KBC Banka A.D. | Full | 100% | ------ | Sold in 4Q 2013 |
| KBC Bank Deutschland AG | Full | 100% | ------ | Sold in 3Q 2014 |
| Transformation fund Stabilita | Full | 100% | ------ | Deconsolidated in 3Q 2014 |
| Name Changes | ||||
| None | ||||
| Changes in ownership percentage and internal mergers | ||||
| KBC Global Services NV | Full | 100% | ------ | Merged with KBC Group NV on 1 July 2013 |
| KBC Consumer Finance NV | Full | 100% | ------ | Merged with KBC Bank NV on 1 January 2014 |
| 31/12/2013 | 30/09/2014 | |||
| Additions | ||||
| None | ||||
| Exclusions | ||||
| KBC Bank Deutschland AG | Full | 100% | ------ | Sold in 3Q 2014 |
| Transformation fund Stabilita | Full | 100% | ------ | Deconsolidated in 3Q 2014 |
| Name Changes | ||||
| None | ||||
| Changes in ownership percentage and internal mergers | ||||
| KBC Consumer Finance NV | Full | 100% | ------ | Merged with KBC Bank NV on 1 January 2014 |
Due to the application of IFRS 11 as from 1 January 2014, the reference figures throughout the consolidated financial statement have been restated to account for the different treatment of the joint venture ČMSS in the Czech Business Unit (from proportionate consolidation to equity method - for more information see note 1a).
Significant events between the balance sheet date (30 September 2014) and the publication of this report (13 November 2014):
On Sunday 26 October, the European Central Bank (ECB) published the results of the comprehensive assessment carried out by the ECB. KBC exceeded both the asset quality review and the stress test thresholds and maintains strong buffers. Based on the recommendations from the ECB, KBC will re-assess individual files. KBC expects these individual re-assessments to have a non-material impact on provisions.
Furthermore, KBC takes notice of the prudential adjustments to its mortgage portfolio in Ireland for an amount of 0.3 billion euros. KBC does not expect to record extra provisions on the basis of this outcome.
Moreover, KBC points out that with regard to the treatment of risk-weighting of sovereign exposure it has been asked by the National Bank of Belgium to abolish the carve-out of a zero-weighting for home-country sovereign exposure already at the end of 2013. This change in treatment increased the RWA starting base of the ECB's comprehensive assessment.
For more information, see the press release of 26 October 2014 on www.kbc.com.
.
KBC Group Risk and capital management 3Q 2014 and 9M 2014
The main source of credit risk is the loan portfolio of the bank. A snapshot of the banking portfolio is shown in the table below. It includes all payment credit, guarantee credit (except for confirmations of letters of credit and similar export-/import-related commercial credit), standby credit and credit derivatives, granted by KBC to private persons, companies, governments and banks. Bonds held in the investment portfolio are included if they are corporate- or bank-issued, hence government bonds and trading book exposure are not included. Further on in this chapter, extensive information is provided on the credit portfolio of each business unit. Structured credit exposure is described separately. Information specifically on sovereign bonds can be found under 'note 47 (in the annual accounts 2013)'. The reference figures of the loan portfolio have been restated to account for the different treatment of the joint venture ČMSS in the Czech Business Unit (from proportional consolidation to equity method - for more information see note 1a of the Consolidated financial statements of this interim report.). Furthermore, all loans of Antwerp Diamond Bank (in wind-down) have been re-included in the reference figures, since the latter entity is no longer recognized as 'disposal group' under IFRS 5.
| Credit risk: loan portfolio overview | 31-12-2013 Pro forma |
30-09-2014 |
|---|---|---|
| Total loan portfolio (in billions of EUR) | ||
| Amount granted | 161 | 165 |
| Amount outstanding1 | 135 | 138 |
| Total loan portfolio, by business unit (as a % of the portfolio of credit outstanding) | ||
| Belgium | 64% | 64% |
| Czech Republic | 13% | 13% |
| International Markets | 19% | 19% |
| Group Centre | 4% | 4% |
| Total | 100% | 100% |
| Impaired loans (in millions of EUR or %) | ||
| Amount outstanding | 13 871 | 14 198 |
| of which: more than 90 days past due | 8 086 | 8 325 |
| Ratio of impaired loans, per business unit | ||
| Belgium | 4.7% | 4.6% |
| Czech Republic | 4.3% | 4.1% |
| International Markets | 33.0% | 34.8% |
| Group Centre | 10.6% | 9.7% |
| Total | 10.2% | 10.3% |
| of which: more than 90 days past due | 6.0% | 6.0% |
| Specific loan loss impairments (in millions of EUR) and Cover ratio (%) | ||
| Specific loan loss impairments | 5 521 | 5 754 |
| of which: more than 90 days past due | 4 046 | 4 459 |
| Cover ratio of impaired loans | ||
| Specific loan loss impairments / impaired loans | 40% | 41% |
| of which: more than 90 days past due | 50% | 54% |
| Cover ratio of impaired loans, mortgage loans excluded | ||
| Specific loan loss impairments / impaired loans, mortgage loans excluded | 47% | 49% |
| of which: more than 90 days past due | 62% | 64% |
| Credit cost, by business unit (%)2 | ||
| Belgium | 0.37% | 0.20% |
| Czech Republic | 0.26% | 0.13% |
| International Markets | 4.48% | 1.09% |
| Slovakia | 0.60% | 0.34% |
| Hungary | 1.50% | 0.92% |
| Bulgaria | 1.19% | 1.19% |
| Ireland | 6.72% | 1.40% |
| Group Centre3 | 2.40% | 1.38% |
| Total3 | 1.21% | 0.40% |
Outstanding amount includes all on-balance sheet commitments and off-balance sheet guarantees
Annualized credit cost.
Including IFRS 5 entities (ex KBC Bank Deutschland) the CCR per 30-09-2014 would be 1.42% for Group Centre and 0.41% for the Total.
Impaired loans are loans for which full (re)payment of the contractual cash flows is deemed unlikely. This coincides with KBC's Probability-of-Default-classes 10+11+12 (see annual report FY 2013 - section on credit risk for more information on PD classification). These impaired loans are equal to 'non-performing loans' under the (new) definition used by EBA.
Legend:
| Loan portfolio Business Unit Belgium 30-09-2014, in millions of EUR |
Belgium | Foreign branches | Total Business Unit Belgium | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Total outstanding amount | 82 848 | 5 288 | 88 136 | ||||||
| Counterparty break down | % outst. | % outst. | % outst. | ||||||
| SME / corporate | 23 267 | 28.1% | 5 288 | 100.0% | 28 555 | 32.4% | |||
| retail | 59 581 | 71.9% | 0 | 0.0% | 59 581 | 67.6% | |||
| o/w private | 32 537 | 39.3% | 0 | 0.0% | 32 537 | 36.9% | |||
| o/w companies | 27 044 | 32.6% | 0 | 0.0% | 27 044 | 30.7% | |||
| Mortgage loans (1) | % outst. ind. LTV | % outst. ind. LTV | % outst. | ||||||
| total | 31 486 | 38.0% | 59% | 0 | 0.0% | - | 31 486 | 35.7% | |
| o/w FX mortgages | 0 | 0.0% | - | 0 | 0.0% | - | 0 | 0.0% | |
| o/w vintage 2007 and 2008 | 2 574 | 3.1% | - | 0 | 0.0% | - | 2 574 | 2.9% | |
| o/w ind. LTV > 100% | 1 517 | 1.8% | - | 0 | 0.0% | - | 1 517 | 1.7% | |
| Probability of default (PD) | % outst. | % outst. | % outst. | ||||||
| low risk (pd 1-4; 0.00%-0.80%) | 61 250 | 73.9% | 2 968 | 56.1% | 64 218 | 72.9% | |||
| medium risk (pd 5-7; 0.80%-6.40%) | 15 930 | 19.2% | 1 393 | 26.3% | 17 322 | 19.7% | |||
| high risk (pd 8-9; 6.40%-100.00%) | 2 182 | 2.6% | 281 | 5.3% | 2 463 | 2.8% | |||
| impaired loans (pd 10 - 12) | 3 397 | 4.1% | 624 | 11.8% | 4 021 | 4.6% | |||
| unrated | 9 0 |
0.1% | 2 3 |
0.4% | 113 | 0.1% | |||
| Overall risk indicators | spec. imp. % cover | spec. imp. % cover | spec. imp. | % cover | |||||
| outstanding impaired loans | 3 397 | 1 362 | 40.1% | 624 | 289 | 46.3% | 4 021 | 1 651 | 41.1% |
| o/w pd 10 impaired loans | 1 392 | 280 | 20.1% | 386 | 115 | 29.9% | 1 779 | 395 | 22.2% |
| o/w more than 90 days past due (pd 11+12) | 2 004 | 1 083 | 54.0% | 238 | 173 | 73.0% | 2 242 | 1 256 | 56.0% |
| all impairments (specific + portfolio based) | n.a. | n.a. | 1 707 | ||||||
| o/w portfolio based impairments | n.a. | n.a. | 5 6 |
||||||
| o/w specific impairments | 1 362 | 289 | 1 651 | ||||||
| 2013 Credit cost ratio (CCR) | n.a. | n.a. | 0.37% | ||||||
| YTD 2014 CCR | n.a. | n.a. | 0.20% |
Remarks
Belgium = KBC Bank (all retail and coporate credit lending activities except for the foreign branches), CBC, KBC Lease part Belgium, KBC Commercial Finance, KBC Credit Investments (part of non-legacy portfolio assigned to BU Belgium)
(1) mortgage loans: only to private persons (as opposed to the accounting figures)
| Loan portfolio Business Unit Czech Republic | For information: ČMSS (consolidated via equity-method since 1Q14) |
||||||
|---|---|---|---|---|---|---|---|
| 30-09-2014, in millions of EUR | Czech republic | Czech Rep (ČMSS) (3) | |||||
| Total outstanding amount | 18 282 | 2 513 | |||||
| Counterparty break down | % outst. | % outst. | |||||
| SME / corporate | 6 355 | 34.8% | 7 4 |
2.9% | |||
| retail | 11 928 | 65.2% | 2 439 | 97.1% | |||
| o/w private | 8 339 | 45.6% | 2 425 | 96.5% | |||
| o/w companies | 3 588 | 19.6% | 1 5 |
0.6% | |||
| Mortgage loans (1) | % outst. | ind. LTV | % outst. | ind. LTV | |||
| total | 7 584 | 41.5% | 65% | 1 875 | 74.6% | 66% | |
| o/w FX mortgages | 0 | 0.0% | - | 0 | 0.0% | - | |
| o/w vintage 2007 and 2008 | 1 311 | 7.2% | - | 284 | 11.3% | - | |
| o/w ind. LTV > 100% | 228 | 1.2% | - | 140 | 5.6% | - | |
| Probability of default (PD) | % outst. | % outst. | |||||
| low risk (pd 1-4; 0.00%-0.80%) | 12 445 | 68.1% | 1 080 | 43.0% | |||
| medium risk (pd 5-7; 0.80%-6.40%) | 4 478 | 24.5% | 1 184 | 47.1% | |||
| high risk (pd 8-9; 6.40%-100.00%) | 466 | 2.6% | 172 | 6.8% | |||
| impaired loans (pd 10 - 12) | 746 | 4.1% | 7 7 |
3.1% | |||
| unrated | 147 | 0.8% | 0 | 0.0% | |||
| Overall risk indicators (2) | spec. imp. | % cover | spec. imp. | % cover | |||
| outstanding impaired loans | 746 | 373 | 50.0% | 7 7 |
2 9 |
37.2% | |
| o/w pd 10 impaired loans | 188 | 3 1 |
16.6% | 2 6 |
2 | 6.8% | |
| o/w more than 90 days past due (pd 11+12) | 558 | 342 | 61.3% | 5 1 |
2 7 |
53.0% | |
| all impairments (specific + portfolio based) | 402 | 3 1 |
|||||
| o/w portfolio based impairments | 2 9 |
3 | |||||
| o/w specific impairments | 373 | 2 9 |
|||||
| 2013 Credit cost ratio (CCR) | 0.26% | n/a | |||||
| YTD 2014 CCR | 0.13% | n/a |
(1) mortgage loans: only to private persons (as opposed to the accounting figures)
(2) individual CCR in local currency
(3) ČMSS: pro-rata figures, corresponding with KBC's 55%-participation in ČMSS
| Loan portfolio Business Unit International Markets 30-09-2014, in millions of EUR |
Ireland | Slovakia | Hungary | Bulgaria | Total Int Markets | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total outstanding amount | 14 590 | 4 921 | 5 178 | 791 | 25 500 | ||||||||||
| Counterparty break down | % outst. | % outst. | % outst. | % outst. | % outst. | ||||||||||
| SME / corporate | 2 702 | 18.5% | 2 032 | 41.3% | 2 772 | 53.5% | 330 | 41.7% | 7 855 | 30.8% | |||||
| retail | 11 889 | 81.5% | 2 889 | 58.7% | 2 406 | 46.5% | 462 | 58.3% | 17 645 | 69.2% | |||||
| o/w private | 11 889 | 81.5% | 2 313 | 47.0% | 1 917 | 37.0% | 278 | 35.1% | 16 396 | 64.3% | |||||
| o/w companies | 0 | 0.0% | 576 | 11.7% | 489 | 9.4% | 184 | 23.2% | 1 249 | 4.9% | |||||
| Mortgage loans (1) | % outst. ind. LTV | % outst. ind. LTV | % outst. ind. LTV | % outst. ind. LTV | % outst. | ||||||||||
| total | 11 889 | 81.5% | 108% | 1 920 | 39.0% | 59% | 1 747 | 33.7% | 94% | 131 | 16.5% | 70% | 15 687 | 61.5% | |
| o/w FX mortgages | 0 | 0.0% | - | 0 | 0.0% | - | 1 320 | 25.5% | 105% | 7 7 |
9.7% | 70% | 1 397 | 5.5% | |
| o/w vintage 2007 and 2008 | 4 403 | 30.2% | - | 173 | 3.5% | - | 886 | 17.1% | - | 3 8 |
4.8% | - | 5 501 | 21.6% | |
| o/w ind. LTV > 100% | 6 446 | 44.2% | - | 0 | 0.0% | - | 709 | 13.7% | - | 1 1 |
1.4% | - | 7 166 | 28.1% | |
| Probability of default (PD) | % outst. | % outst. | % outst. | % outst. | % outst. | ||||||||||
| low risk (pd 1-4; 0.00%-0.80%) | 2 767 | 19.0% | 3 333 | 67.7% | 1 911 | 36.9% | 103 | 13.0% | 8 097 | 31.8% | |||||
| medium risk (pd 5-7; 0.80%-6.40%) | 3 456 | 23.7% | 963 | 19.6% | 2 113 | 40.8% | 369 | 46.7% | 6 906 | 27.1% | |||||
| high risk (pd 8-9; 6.40%-100.00%) | 688 | 4.7% | 311 | 6.3% | 406 | 7.8% | 6 5 |
8.2% | 1 476 | 5.8% | |||||
| impaired loans (pd 10 - 12) | 7 680 | 52.6% | 218 | 4.4% | 740 | 14.3% | 239 | 30.2% | 8 877 | 34.8% | |||||
| unrated | 0 | 0.0% | 9 6 |
2.0% | 8 | 0.2% | 1 6 |
2.0% | 145 | 0.6% | |||||
| Overall risk indicators (2) | spec. imp. % cover | spec. imp. % cover | spec. imp. % cover | spec. imp. % cover | spec. imp. % cover | ||||||||||
| outstanding impaired loans | 7 680 2 797 | 36.4% | 218 | 105 | 48.2% | 740 | 394 | 53.3% | 239 | 9 2 |
38.7% | 8 877 3 389 | 38.2% | ||
| o/w pd 10 impaired loans | 3 545 | 766 | 21.6% | 5 5 |
1 7 |
30.5% | 152 | 5 4 |
35.6% | 3 4 |
0 | 1.2% | 3 787 | 838 | 22.1% |
| o/w more than 90 days past due (pd 11+12) | 4134 2 031 | 49.1% | 163 | 8 8 |
54.1% | 587 | 340 | 57.9% | 205 | 9 2 |
44.9% | 5090 2 551 | 50.1% | ||
| all impairments (specific + portfolio based) | 2870 | 116 | 414 | 9 4 |
3494 | ||||||||||
| o/w portfolio based impairments | 7 3 |
1 1 |
2 0 |
1 | 105 | ||||||||||
| o/w specific impairments | 2797 | 105 | 394 | 9 2 |
3389 | ||||||||||
| 2013 Credit cost ratio (CCR) | 6.72% | 0.60% | 1.50% | 1.19% | 4.48% | ||||||||||
| YTD 2014 CCR | 1.40% | 0.34% | 0.92% | 1.19% | 1.09% | ||||||||||
Remarks
Ireland = KBC Bank Ireland (incl. former KBC Homeloans)
Total Int Markets: outstanding additionally includes small amount of KBC internal risk sharings which were eliminated at country level
(1) mortgage loans: only to private persons (as opposed to the accounting figures); For Ireland: only KBC Homeloans exposure
(2) individual CCR in local currency
| Total Group Centre (mainly KBC Finance Ireland, KBC 30-09-2014, in millions of EUR Credit Investments and Antwerp Diamond Bank (in wind-down)) Total outstanding amount 5 713 Counterparty break down % outst. SME / corporate 5 711 100.0% retail 2 0.0% o/w private 2 0.0% o/w companies 0 0.0% Mortgage loans (1) % outst. ind. LTV total 0 0.0% - o/w FX mortgages 0 0.0% - o/w vintage 2007 and 2008 0 0.0% - o/w ind. LTV > 100% 0 0.0% - Probability of default (PD) % outst. low risk (pd 1-4; 0.00%-0.80%) 2 168 37.9% medium risk (pd 5-7; 0.80%-6.40%) 2 334 40.8% high risk (pd 8-9; 6.40%-100.00%) 623 10.9% impaired loans (pd 10 - 12) 554 9.7% unrated 3 4 0.6% Overall risk indicators (2) spec. Imp. % cover outstanding impaired loans 554 341 61.5% o/w pd 10 impaired loans 119 3 1 25.8% o/w more than 90 days past due (pd 11+12) 435 310 71.2% all impairments (specific + portfolio based) 359 o/w portfolio based impairments 1 8 o/w specific impairments 341 2013 Credit cost ratio (CCR) 2.90% YTD 2014 CCR 1.38% |
Loan portfolio Group Centre | ||||||
|---|---|---|---|---|---|---|---|
Remarks
Total Group Centre = KBC Finance Ireland, KBC Credit Investments (legacy & and part of non-legacy portfolio assigned to BU Group), Antwerp Diamond Bank (in wind-down), KBC FP (ex-Atomium assets), KBC Lease UK, KBC Bank part Group
(1) mortgage loans: only to private persons (as opposed to the accounting figures)
(2) individual CCR in local currency
Standing at more than 25 billion euros in 2008, KBC has fully scaled down its CDO portfolio with the last action taking place in September 2014 by collapsing the last two remaining CDOs originated by KBC FP. These collapses ended the guarantee agreement with the Belgian State for KBC and completely eliminates the group's exposure to MBIA.
For the record, KBC wishes to point out that it is the counterparty to and issuer of a further 0.3 billion euros' worth of CDO notes issued by KBC FP and held by third-party investors that will remain outstanding until November 2017. Consequently, negligible movements may yet be recorded in KBC's income statement in the coming quarters based on changes in the value of these notes (due primarily to credit spreads on the underlying portfolio). For more information, see the press release of 1 October 2014 on www.kbc.com.
Since 2008, KBC has a tight strategy in place related to structured credit products and gradually imposed a moratorium on all origination and investment activity in CDOs and ABS. In 4Q13 KBC decided to lift the strict moratorium on investments in ABS and to allow new treasury investments in high quality ABS. This allows a further diversification of the investment portfolios. Important to note is that the moratorium on investments in synthetic securitizations or re-securitisations continues to exist.
The total amount of these treasury investments stands at 0.9 billion euros as at 30 September 2014. Next to the treasury ABS, (i) a portfolio for an amount of 0.7 billion euros of other (legacy) ABS and (ii) a small portfolio of below 0.1 billion euros not by KBC FP originated CDOs continue to exist.
KBC reports its solvency at group, banking and insurance level, calculating it on the basis of IFRS figures and the relevant guidelines issued by the Belgian regulator.
Under Basel III (CRDIV/CRR), which is the applicable guideline as from 1 January 2014 onward, for group solvency the insurance participation is to be deducted from common equity at KBC Group level, unless the competent authority grants the permission to apply a risk weighting instead. KBC received this permission from the National Bank of Belgium (NBB) and will allocate a 370% weighting to the holdings of own funds instruments of the insurance company, after having deconsolidated KBC Insurance from the KBC Group consolidated figures. This is the so-called 'Danish compromise'.
In addition to this calculation method, KBC has to disclose also the capital adequacy ratio as calculated in accordance with the 'building block' method. This entails comparing group regulatory capital (i.e. parent shareholders' equity less intangible assets and a portion of the revaluation reserve for available-for-sale assets, plus subordinated debt, etc.) with the sum of the separate minimum regulatory solvency requirements for KBC Bank, the holding company (after deduction of intercompany transactions between these entities) and KBC Insurance. The total risk-weighted volume of insurance companies is calculated as the required solvency margin under Solvency I divided by 8%.
The NBB has confirmed to KBC that the non-voting core capital securities will be fully grandfathered as common equity under CRDIV until the end of 2017.
KBC's own minimum target for the common equity ratio is 10.5% on a fully loaded basis (presuming full implementation of all CRDIV/CRR rules and including the remaining Flemish government support until 2018). KBC's fully loaded common equity ratio stood at 13.7% as at the end of September 2014.
Moreover, the supervisory authorities, with the NBB as the consolidating supervisor, have requested KBC to minimally uphold a fully loaded common equity ratio, excluding latent gains, of 9.25%. According to this calculation, KBC's fully loaded common equity ratio stood at 13.1% as at the end of September 2014.
The Internal Rating Based (IRB) approach is since its implementation in 2008 the primary approach to calculated KBC's risk weighted assets. This is, based on a full application of all the CRD IV/CRR rules, used for approximately 80% of the weighted credit risks, of which approx. 64% according to Advanced and approx. 15% according to Foundation approach. Note that, retail exposure treated under IRB is always subject to an Advanced approach. The remaining weighted credit risks (ca. 21%) are calculated according to the Standardised approach. The latter, under the Danish Compromise, includes the 370% risk-weighted holdings of own funds instruments of the insurance company.
| In millions of EUR | 31-12-2013 | 30-09-2014 |
|---|---|---|
| Danish compromise - Fully loaded | ||
| Total regulatory capital, KBC Group (after profit appropriation) | 16 258 | 15 376 |
| Tier-1 capital | 11 711 | 13 885 |
| Common equity | 11 711 | 12 485 |
| Parent shareholders' equity (after deconsolidating KBC Insurance) | 11 361 | 12 050 |
| Non-voting core capital securities | 2 333 | 2 000 |
| Intangible fixed assets (incl deferred tax impact) (-) | - 341 | - 339 |
| Goodwill on consolidation (incl deferred tax impact) (-) | - 950 | - 775 |
| Minority interests | - 3 | - 3 |
| Hedging reserve (cash flow hedges) (-) | 497 | 1 104 |
| Valuation diff. in fin. liabilities at fair value - own credit risk (-) | - 6 | - 4 |
| Equalization reserve (-) | - 131 | |
| Dividend payout (-) | 0 | - 626 |
| Renumeration of government securities (-) | 0 | - 127 |
| Renumeration of AT1 instruments (-) | 0 | - 2 |
| Deduction re. financing provided to shareholders (-) | - 176 | - 158 |
| IRB provision shortfall (-) | - 225 | - 273 |
| Deferred tax assets on losses carried forward (-) | - 648 | - 362 |
| Limit on deferred tax assets from timing differences relying on future | ||
| profitability and significant participations in financial sector entities (-) | 0 | 0 |
| Additional going concern capital | 0 | 1 400 |
| Grandfathered innovative hybrid tier-1 instruments | 0 | 0 |
| Grandfathered non-innovative hybrid tier-1 instruments | 0 | 0 |
| CRR compliant AT1 instruments | 0 | 1 400 |
| Minority interests to be included in additional going concern capital | 0 | 0 |
| Tier 2 capital | 4 547 | 1 491 |
| IRB provision excess (+) | 342 | 367 |
| Subordinated liabilities1 | 4 206 | 1 123 |
| Subordinated loans non-consolidated financial sector entities (-) | 0 | 0 |
| Minority interests to be included in tier 2 capital | 0 | 0 |
| Capital requirement | ||
| Total weighted risk volume2,3,4 | 91 216 | 91 048 |
| Banking | 80 189 | 79 791 |
| Insurance | 11 068 | 11 068 |
| Holding activities | 72 | 247 |
| Elimination of intercompany transactions | - 113 | - 57 |
| Solvency ratios | ||
| Common equity ratio | 12.84% | 13.71% |
| Tier-1 ratio | 12.84% | 15.25% |
| CAD ratio | 17.82% | 16.89% |
1.The decrease in subordinated liabilities is amongst other things the result of the call of almost all KBC's classic subordinated instruments. 2 Until the end of 2014, KBC Group's RWA include a yearly decreasing amount of RWA for residual operational risks related to KBL EPB (sold in 2012).
The reference figures on total weighted risk volume have been restated to account for the different treatment of the joint venture ČMSS in the Czech Business Unit (from proportionate consolidation to equity method - for more information see note 1a of the Consolidated financial statements of this interim report.).
As from 1Q 2014 the RWA methodology changed whereby the 'carve out' of the home-country sovereign bonds (risk weighting these at zero percent) was not applied anymore. This change increased RWA by approximately 4.4 billion euros as calculated based on positions as at the end of 2013.
Following table groups the solvency on the level of KBC according to different methodologies and calculation methods.
| Overview of KBC Group CET ratio | Danish Compromise | Building Block Method | ||
|---|---|---|---|---|
| Fully loaded | Phased-in | Fully loaded | Phased-in | |
| In millions of EUR - 30-09-2014 | ||||
| Common equity | 12 485 | 12 213 | 12 950 | 11 609 |
| Total weighted risk volume | 91 048 | 87 267 | 92 141 | 88 359 |
| Common equity ratio | 13.71% | 14.00% | 14.05% | 13.14% |
The tables below show the tier-1 and CAD ratios calculated under Basel III/CRD IV Danish Compromise for KBC Bank, as well as the solvency ratio of KBC Insurance. More information on the solvency of KBC Bank and KBC Insurance as at 31-12-2013 can be found in their consolidated financial statements and in the KBC Risk Report on www.kbc.com.
| Total regulatory capital, after profit appropriation 14 400 |
13 765 11 439 |
|---|---|
| Tier-1 capital 9 602 |
|
| Of which common equity 9 602 |
10 039 |
| Tier-2 capital 4 797 |
2 326 |
| Total weighted risks 79 822 |
79 424 |
| Credit risk 64 776 |
66 089 |
| Market risk 4 308 |
2 597 |
| Operational risk 10 738 |
10 738 |
| Solvency ratios | |
| Common equity ratio 12.0% |
12.6% |
| Tier-1 ratio 12.0% |
14.4% |
| CAD ratio 18.0% |
17.3% |
| Solvency, KBC Insurance consolidated (in millions of EUR) 31-12-2013 |
30-09-2014 |
| Available capital 2 721 |
3 204 |
| Required solvency margin 968 |
973 |
| Solvency ratio and surplus | |
| Solvency ratio (%) 281% |
329% |
| Solvency surplus (in millions of EUR) 1 753 |
2 231 |
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.